syndrome	score	normalized_score
DRAVET SYNDROME	2.6655187	100.0
CHILDHOOD ABSENCE EPILEPSY	1.5207408500000001	57.052342195160755
MYOCLONIC-ASTASTIC EPILEPSY	1.2186896	45.7205421218767
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.1936939999999998	44.78280343709462
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	1.1521162600000001	43.22296669687593
MOWAT-WILSON SYNDROME; MOWS	1.004112849	37.67044849469636
HEMIDYSTONIA-HEMIATROPHY SYNDROME	1.000541419	37.53646219026713
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.0	37.51615023372374
EHLERS-DANLOS SYNDROME, TYPE I	1.0	37.51615023372374
DYSTROPHIC EPIDERMOLYSIS BULLOSA	1.0	37.51615023372374
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	1.0	37.51615023372374
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	1.0	37.51615023372374
AMOEBIC KERATITIS	1.0	37.51615023372374
PAROXYSMAL KINESIGENIC DYSKINESIA	1.0	37.51615023372374
MYOCLONIC EPILEPSY OF LAFORA	0.93444076	35.05661993667499
LAFORA DISEASE	0.7715289599999999	28.944796373028638
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.7706171	28.910586896276513
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.74803341	28.06333378940467
EARLY MYOCLONIC ENCEPHALOPATHY	0.7081833599999999	26.56831332678326
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.7049018599999999	26.445204079791296
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.704112849	26.415603424579242
PALLISTER-HALL SYNDROME	0.6827075	25.61255713568995
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.59274141	22.23737578730924
ROLANDIC EPILEPSY	0.5906213	22.157837422037222
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.5685520500000001	21.329884123491617
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.5555556	20.842307352786534
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.5333330000000001	20.00860095260259
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.527027	19.772024109228724
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.51630151	19.369645015058424
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.51330784	19.25733404158823
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.51057256	19.154716866176926
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.51057256	19.154716866176926
ACITRETIN/ETRETINATE EMBRYOPATHY	0.50840336	19.073336833089936
EPILEPSY, BENIGN NEONATAL, 2	0.50704225	19.022273225845314
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.50357143	18.8920614212911
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.500541419	18.778387073405263
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.5	18.75807511686187
GIANT AXONAL NEUROPATHY	0.5	18.75807511686187
CREST SYNDROME	0.5	18.75807511686187
EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC	0.5	18.75807511686187
RESTRICTIVE DERMOPATHY	0.5	18.75807511686187
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	18.75807511686187
INHALATIONAL ANTHRAX	0.5	18.75807511686187
DUPLICATION OF THE PITUITARY GLAND	0.5	18.75807511686187
PAROXYSMAL HEMICRANIA	0.5	18.75807511686187
BRANCHIOOTORENAL SYNDROME 1	0.5	18.75807511686187
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.4340692500000001	16.284607194839793
SHEEHAN SYNDROME	0.42590062999999995	15.978152019717587
PANHYPOPHYSITIS	0.42232919999999996	15.84416571528836
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.421542349	15.814646094960805
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.42074085000000006	15.784576938064628
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.41675495	15.635041314848028
SPINOCEREBELLAR ATAXIA TYPE 10	0.4088913	15.340027440062606
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.3905390099999999	14.651520171289736
CANAVAN DISEASE	0.37037	13.894856562064263
ADENOHYPOPHYSITIS	0.3667736	13.759933479363697
FUNCTIONING GONADOTROPIC ADENOMA	0.36556799999999995	13.71470400864192
PERIORAL MYOCLONIA WITH ABSENCES	0.36455991	13.676884352752804
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.35751765999999996	13.412686243769365
EPILEPSY, JUVENILE ABSENCE	0.35751765999999996	13.412686243769365
NON-FUNCTIONING PITUITARY ADENOMA	0.356203919	13.363399739045162
CENTRALOPATHIC EPILEPSY	0.35470090000000004	13.307012252437023
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.3448273	12.936592791489327
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.3448273	12.936592791489327
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.34371795	12.894974250227545
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.34259226	12.852742695070946
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.34037525	12.769569014841279
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.33604361899999996	12.607062895488221
COG4-CDG	0.3355022	12.58675093894483
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.333874419	12.525682862401228
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.333333	12.505370905857834
OROFACIODIGITAL SYNDROME TYPE 3	0.333333	12.505370905857834
ROLANDIC EPILEPSY-PAROXYSMAL EXERCISE-INDUCED DYSTONIA-WRITER'S CRAMP SYNDROME	0.333333	12.505370905857834
EPIDERMAL NEVUS SYNDROME	0.333333	12.505370905857834
NEUROMYELITIS OPTICA	0.333333	12.505370905857834
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	0.333333	12.505370905857834
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.31971448999999996	11.994456838738365
POST-TRAUMATIC PITUITARY DEFICIENCY	0.30306799999999995	11.369944619034184
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.30073585999999997	11.282451704428109
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.2970851	11.14548924380084
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.2970851	11.14548924380084
PANHYPOPITUITARISM	0.29600092999999994	11.104815359201943
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.25668018000000004	9.629652194899254
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.25508440000000004	9.569784672679283
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.25357143	9.513023862860164
HYPEREKPLEXIA 1; HKPX1	0.25	9.379037558430936
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25	9.379037558430936
CONGENITAL FACTOR II DEFICIENCY	0.25	9.379037558430936
HEMOPHILIA B	0.25	9.379037558430936
SEVERE HEMOPHILIA A	0.25	9.379037558430936
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.25	9.379037558430936
PITUITARY APOPLEXY	0.24407850000000003	9.156885674821941
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.2424996	9.097651425217915
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.237037	8.892715702951175
TRICHOTHIODYSTROPHY	0.237037	8.892715702951175
LENNOX-GASTAUT SYNDROME	0.23257130999999998	8.725180206013935
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.22592915000000002	8.475991933577507
ANOPHTHALMIA-MEGALOCORNEA-CARDIOPATHY-SKELETAL ANOMALIES SYNDROME	0.22222260000000002	8.336936446928698
POLYARTERITIS NODOSA	0.2208333	8.284815259408985
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.22016199999999997	8.259630667757085
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.21630151	8.1147999449413
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.213348919	8.004030097406558
MENINGIOMA	0.20982910000000002	7.871980039007043
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.20952369999999998	7.860522606725663
AUTOIMMUNE HYPOPARATHYROIDISM	0.20952369999999998	7.860522606725663
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.20921145000000002	7.848808188815185
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.20518830000000002	7.697875089002378
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.20216920000000002	7.584610079831743
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.20216920000000002	7.584610079831743
ROMANO-WARD SYNDROME	0.200541419	7.523542003288142
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.2	7.50323004674475
MALARIA	0.2	7.50323004674475
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.2	7.50323004674475
BENIGN SCHWANNOMA	0.2	7.50323004674475
46,XY OVOTESTICULAR DISORDER OF SEX DEVELOPMENT	0.2	7.50323004674475
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.2	7.50323004674475
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.2	7.50323004674475
FAMILIAL HYPERALDOSTERONISM TYPE I	0.2	7.50323004674475
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.19807121900000002	7.430869608980798
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.1953606	7.329177619350411
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.1944448	7.294820328966367
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.18939175000000003	7.105249346027849
DEAFNESS, SENSORINEURAL, WITH PITUITARY DWARFISM	0.18841599999999997	7.068642962437292
PITUITARY DEFICIENCY DUE TO RATHKE CLEFT CYSTS	0.1877108	7.04218657329247
JUVENILE MYOCLONIC EPILEPSY	0.18297529999999998	6.864528843860672
MYOCLONIC EPILEPSY OF INFANCY	0.18074025999999999	6.780678747442289
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.18074025999999999	6.780678747442289
CENTRAL CONGENITAL HYPOTHYROIDISM	0.17835963	6.69136667471138
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.17835963	6.69136667471138
NON-ACQUIRED COMBINED PITUITARY HORMONE DEFICIENCY-SENSORINEURAL HEARING LOSS-SPINE ABNORMALITIES SYNDROME	0.17826650000000002	6.687872795640113
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.1713221	6.427345641957043
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.1713221	6.427345641957043
STICKLER SYNDROME	0.17071558	6.404591346517284
GANGLIOCYTOMA	0.17063479999999998	6.401560791901403
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.16988399999999998	6.373393666305923
PROLACTINOMA	0.168169619	6.309076691152082
UNILATERAL POLYMICROGYRIA	0.1680017	6.302777016720987
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.16769681900000002	6.291339055321579
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.167208419	6.273016167547428
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.167208419	6.273016167547428
VICI SYNDROME; VICIS	0.167208419	6.273016167547428
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.167208419	6.273016167547428
CHRONIC INTESTINAL PSEUDOOBSTRUCTION	0.166667	6.252704211004036
STICKLER SYNDROME TYPE 1	0.166667	6.252704211004036
DERMATOLEUKODYSTROPHY	0.166667	6.252704211004036
STICKLER SYNDROME TYPE 2	0.166667	6.252704211004036
CEREBROOCULONASAL SYNDROME	0.166667	6.252704211004036
SCHIZENCEPHALY	0.166667	6.252704211004036
MUCOLIPIDOSIS TYPE II	0.166667	6.252704211004036
STICKLER SYNDROME, TYPE II	0.166667	6.252704211004036
PANHYPOPITUITARISM, X-LINKED	0.1666666	6.252689204543942
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.16654639999999998	6.248179763285847
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.16361056	6.138038348783672
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.15950570000000003	5.98403980433527
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.15950570000000003	5.98403980433527
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.156139849	5.85776603255494
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.15435129999999997	5.790666559570563
WRINKLY SKIN SYNDROME	0.15435129999999997	5.790666559570563
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.15349529999999997	5.758552734970495
PITUITARY STALK INTERRUPTION SYNDROME	0.15256841899999998	5.723779728125711
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.15211625999999998	5.7068164631521805
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.15211625999999998	5.7068164631521805
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.1515915	5.6871294881555325
RESTRICTIVE DERMOPATHY, LETHAL	0.15126035999999998	5.674706390167137
COMBINED SAPOSIN DEFICIENCY	0.1450262	5.440824707026066
HYPOGONADOTROPIC HYPOGONADISM-RETINITIS PIGMENTOSA SYNDROME	0.1435898	5.386936508830345
DE BARSY SYNDROME	0.14285699999999998	5.3594446739390715
FAMILIAL ALZHEIMER-LIKE PRION DISEASE	0.14285699999999998	5.3594446739390715
EHLERS-DANLOS SYNDROME, TYPE VI	0.14285699999999998	5.3594446739390715
FAMILIAL ISOLATED HYPERPARATHYROIDISM	0.14285699999999998	5.3594446739390715
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.14285699999999998	5.3594446739390715
PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT	0.14285699999999998	5.3594446739390715
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.14285699999999998	5.3594446739390715
CONGENITAL FACTOR XIII DEFICIENCY	0.14285699999999998	5.3594446739390715
CARNEY COMPLEX	0.14285699999999998	5.3594446739390715
HEREDITARY THROMBOPHILIA DUE TO CONGENITAL ANTITHROMBIN DEFICIENCY	0.14285699999999998	5.3594446739390715
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.14089110999999999	5.285692049356097
CULLER-JONES SYNDROME; CJS	0.13813799999999998	5.18240596098613
FRONTORHINY	0.13813799999999998	5.18240596098613
PITUITARY CARCINOMA	0.13813799999999998	5.18240596098613
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.1324787	4.970090811968418
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.1303205	4.889123456533995
TSH-SECRETING PITUITARY ADENOMA	0.12970811899999998	4.8661492789377165
ANE SYNDROME	0.12602290000000002	4.727894049289545
TETRAAMELIA-MULTIPLE MALFORMATIONS SYNDROME	0.125	4.689518779215468
RHOMBENCEPHALOSYNAPSIS	0.125	4.689518779215468
CRANIOTELENCEPHALIC DYSPLASIA	0.125	4.689518779215468
PITUITARY DWARFISM WITH LARGE SELLA TURCICA	0.12174929999999999	4.5675650296507015
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.12037025999999999	4.515828757832387
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.11927242899999999	4.474642365105148
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.11815324999999999	4.432655077602719
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.11815324999999999	4.432655077602719
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.11796314999999999	4.425523257443289
NEPHROGENIC DIABETES INSIPIDUS	0.11739304899999999	4.404135262678892
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.1152645	4.324280298615051
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.11165241899999999	4.188768925162671
ISOLATED BILIARY ATRESIA	0.11165241899999999	4.188768925162671
ACROMELIC FRONTONASAL DYSPLASIA	0.11165241899999999	4.188768925162671
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.1114059	4.179520481323204
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.11111099999999999	4.168456968619278
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.11111099999999999	4.168456968619278
EXUDATIVE VITREORETINOPATHY 3; EVR3	0.11111099999999999	4.168456968619278
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.11111099999999999	4.168456968619278
EXUDATIVE VITREORETINOPATHY 4	0.11111099999999999	4.168456968619278
EXUDATIVE VITREORETINOPATHY 5; EVR5	0.11111099999999999	4.168456968619278
NEPHROGENIC DIABETES INSIPIDUS - INTRACRANIAL CALCIFICATION	0.11111099999999999	4.168456968619278
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.11111099999999999	4.168456968619278
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.11111099999999999	4.168456968619278
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.11111099999999999	4.168456968619278
CYSTINOSIS	0.11111099999999999	4.168456968619278
SATOYOSHI SYNDROME	0.11111099999999999	4.168456968619278
HYPERTRIGLYCERIDEMIA, FAMILIAL	0.11111099999999999	4.168456968619278
PITUITARY DWARFISM WITH SMALL SELLA TURCICA	0.11111099999999999	4.168456968619278
EXUDATIVE VITREORETINOPATHY 6; EVR6	0.11111099999999999	4.168456968619278
HYPERLIPOPROTEINEMIA, TYPE IV	0.11111099999999999	4.168456968619278
BARDET-BIEDL SYNDROME 1; BBS1	0.11111099999999999	4.168456968619278
PITUITARY DWARFISM IV	0.11111099999999999	4.168456968619278
RHYNS SYNDROME	0.11111099999999999	4.168456968619278
BILATERAL POLYMICROGYRIA	0.10628441	3.98738189306269
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.10625166	3.9861532391425354
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.10621331	3.984714494781073
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.10591140000000002	3.9733879938640095
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.10591140000000002	3.9733879938640095
SCHINZEL-GIEDION SYNDROME	0.10591140000000002	3.9733879938640095
PITUICYTOMA	0.10465540000000001	3.9262677091704523
AICARDI SYNDROME; AIC	0.1036867	3.8899258144390436
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.10170259999999999	3.815490020760312
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.10153924	3.809361382458131
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.09997559999999998	3.7506996293066712
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.09840755000000001	3.6918724299326815
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.09812185	3.681154065810906
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.09812185	3.681154065810906
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.09812185	3.681154065810906
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.09812185	3.681154065810906
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.09812185	3.681154065810906
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.0978483	3.670891522914471
CRANIOPHARYNGIOMA	0.09455851900000001	3.5474716046824213
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.09398854999999999	3.526088562049855
HARTSFIELD SYNDROME; HRTFDS	0.09369369999999999	3.5150269251534416
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.0925926	3.4737178921310887
HOLOPROSENCEPHALY	0.090744029	3.4043666247773845
NELSON SYNDROME	0.0858505	3.2207802556403
SEPTOOPTIC DYSPLASIA	0.08491749999999999	3.1857776874722354
CHARGE SYNDROME	0.0794742	2.9815660269050075
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.07904281	2.9653819348556816
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.077846419	2.920497950361406
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.07692310000000001	2.885858576043755
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.07692310000000001	2.885858576043755
PROLACTIN DEFICIENCY, ISOLATED	0.07692310000000001	2.885858576043755
PROLACTIN DEFICIENCY WITH OBESITY AND ENLARGED TESTES	0.07692310000000001	2.885858576043755
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.07692310000000001	2.885858576043755
WEBB-DATTANI SYNDROME; WEDAS	0.076668219	2.876296422156033
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.07655338	2.8719881049793425
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.0763091	2.8628236598002488
GRANULOMATOSIS WITH POLYANGIITIS	0.075187419	2.8207425068899354
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.07418598	2.7831723709160245
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.07378314999999999	2.7680597401173737
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.07372048	2.765708602982227
MELAS	0.07348576	2.7569028121993666
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.07289361	2.734687623838467
TUBEROUS SCLEROSIS COMPLEX	0.0715302	2.683537729448306
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.07142860000000001	2.67972608858456
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.07142860000000001	2.67972608858456
HYPEREKPLEXIA-EPILEPSY SYNDROME	0.0686937	2.5771231693103487
EMANUEL SYNDROME	0.067317009	2.5254750229289336
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.067208119	2.5213898893299826
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.067208119	2.5213898893299826
ICHTHYOSIS AND MALE HYPOGONADISM	0.067208119	2.5213898893299826
MONOSOMY 18Q	0.067208119	2.5213898893299826
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.067208119	2.5213898893299826
PALLISTER-HALL SYNDROME	0.066735319	2.5036522534994785
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.0666667	2.5010779327865906
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.0666667	2.5010779327865906
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.0666667	2.5010779327865906
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.0666667	2.5010779327865906
HYPOGONADOTROPIC HYPOGONADISM 8 WITH OR WITHOUT ANOSMIA; HH8	0.0666667	2.5010779327865906
ISOLATED FOLLICLE STIMULATING HORMONE DEFICIENCY	0.0666667	2.5010779327865906
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.0666667	2.5010779327865906
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.0666667	2.5010779327865906
HYPERGONADOTROPIC HYPOGONADISM-CATARACT SYNDROME	0.0666667	2.5010779327865906
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.0666667	2.5010779327865906
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.0666667	2.5010779327865906
FAMILIAL ISOLATED HYPOPARATHYROIDISM DUE TO AGENESIS OF PARATHYROID GLAND	0.0666667	2.5010779327865906
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.066612849	2.4990576505803546
CONGENITAL HYPOTHYROIDISM	0.06644351	2.4927047032159257
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.0663574	2.4894741875193
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.0661939	2.483340296956086
JOUBERT SYNDROME 26	0.0661939	2.483340296956086
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	0.0661939	2.483340296956086
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.06535621900000001	2.4519137307121506
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.065147809	2.4440949898419397
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.0648148	2.4316017741687577
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.0648148	2.4316017741687577
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.0645682	2.4223502915211217
MICROFORM HOLOPROSENCEPHALY	0.06450037900000001	2.4198059086961203
ADNP SYNDROME	0.064436019	2.417391369267077
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.064436019	2.417391369267077
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.0634556	2.3806098227710804
KNOBLOCH SYNDROME	0.063041419	2.3650713461511264
ACTH DEFICIENCY, ISOLATED; IAD	0.063041419	2.3650713461511264
KNOBLOCH SYNDROME 1; KNO1	0.063041419	2.3650713461511264
PETERS PLUS SYNDROME	0.06287208	2.3587183987866975
CHARGE SYNDROME	0.06287208	2.3587183987866975
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.06259785000000001	2.3484303449081043
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.06251996	2.345508211966399
VITREORETINAL DEGENERATION, SNOWFLAKE TYPE; SVD	0.0625	2.344759389607734
ENHANCED S-CONE SYNDROME	0.0625	2.344759389607734
STICKLER SYNDROME, TYPE V; STL5	0.0625	2.344759389607734
ADRENOCORTICAL CARCINOMA	0.0625	2.344759389607734
MARSHALL SYNDROME	0.0625	2.344759389607734
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.0625	2.344759389607734
VITREORETINOPATHY, NEOVASCULAR INFLAMMATORY	0.0625	2.344759389607734
PIGMENTED PARAVENOUS CHORIORETINAL ATROPHY	0.0625	2.344759389607734
EXUDATIVE VITREORETINOPATHY 7; EVR7	0.0625	2.344759389607734
AUTOSOMAL RECESSIVE STICKLER SYNDROME	0.0625	2.344759389607734
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.0625	2.344759389607734
COMBINED HAMARTOMA OF THE RETINA AND RETINAL PIGMENT EPITHELIUM	0.0625	2.344759389607734
KNIEST DYSPLASIA	0.0625	2.344759389607734
WHITE-SUTTON SYNDROME; WHSUS	0.06129623000000001	2.2995985734408846
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.06103496	2.289796728869319
SEVERE CONGENITAL NEMALINE MYOPATHY	0.06103496	2.289796728869319
KNIEST-LIKE DYSPLASIA, LETHAL	0.06103496	2.289796728869319
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0607197	2.2779693873466353
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.05960418000000001	2.2361193714379124
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.05960418000000001	2.2361193714379124
ENDOCARDIAL FIBROELASTOSIS	0.059364919	2.2271432198168415
KALLMANN SYNDROME	0.059364919	2.2271432198168415
TRIPLE A SYNDROME	0.059364919	2.2271432198168415
GITELMAN SYNDROME	0.059127030000000004	2.218218540353891
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.059127030000000004	2.218218540353891
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.0588235	2.2068312632734486
X-LINKED HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.0588235	2.2068312632734486
SOMATOMAMMOTROPINOMA	0.0588235	2.2068312632734486
NON-ACQUIRED ISOLATED GROWTH HORMONE DEFICIENCY	0.0588235	2.2068312632734486
601016 MIDLINE MALFORMATIONS, MULTIPLE, WITH LIMB ABNORMALITIES AND HYPOPITUITARISM;;DINCSOY SYNDROME	0.0588235	2.2068312632734486
KEARNS-SAYRE SYNDROME	0.0588235	2.2068312632734486
ACROMEGALY	0.0588235	2.2068312632734486
SHORT STATURE-WORMIAN BONES-DEXTROCARDIA SYNDROME	0.0588235	2.2068312632734486
241800 HYPOTHALAMIC HAMARTOMASCONGENITAL HYPOTHALAMIC HAMARTOMA SYNDROME, INCLUDED; CHHS, INCLUDED	0.0588235	2.2068312632734486
BOHRING-OPITZ SYNDROME	0.05826621900000001	2.1859242255550493
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.0578905	2.1718286951053845
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.05777791	2.1676047517505697
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.057221599000000005	2.1467341046978965
MEIER-GORLIN SYNDROME 1; MGORS1	0.056680180000000004	2.126422148154504
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.056249549999999995	2.1102665683793553
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.056097019000000005	2.1045441924680555
CRYPTOCOCCOSIS	0.056097019000000005	2.1045441924680555
HOLOPROSENCEPHALY 7	0.056097019000000005	2.1045441924680555
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.056097019000000005	2.1045441924680555
MALIGNANT ATROPHIC PAPULOSIS	0.056097019000000005	2.1045441924680555
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.055555600000000004	2.084232235924663
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	2.084232235924663
PSEUDOXANTHOMA ELASTICUM-LIKE SKIN MANIFESTATIONS WITH RETINITIS PIGMENTOSA	0.055555600000000004	2.084232235924663
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.055555600000000004	2.084232235924663
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.055555600000000004	2.084232235924663
OCULOCUTANEOUS ALBINISM TYPE 4	0.055555600000000004	2.084232235924663
OCULOCUTANEOUS ALBINISM TYPE 1B	0.055555600000000004	2.084232235924663
OCULOCUTANEOUS ALBINISM TYPE 2	0.055555600000000004	2.084232235924663
OCULOCUTANEOUS ALBINISM TYPE 1A	0.055555600000000004	2.084232235924663
CONGENITAL ISOLATED ACTH DEFICIENCY	0.055555600000000004	2.084232235924663
HOLOPROSENCEPHALY 3; HPE3	0.055555600000000004	2.084232235924663
HERMANSKY-PUDLAK SYNDROME	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	2.084232235924663
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 4	0.055555600000000004	2.084232235924663
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 3	0.055555600000000004	2.084232235924663
CONE-ROD DYSTROPHY 8; CORD8	0.055555600000000004	2.084232235924663
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.055555600000000004	2.084232235924663
FRIED SYNDROME	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.055555600000000004	2.084232235924663
VACTERL WITH HYDROCEPHALUS	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.055555600000000004	2.084232235924663
LEUKOENCEPHALOPATHY-SPONDYLOMETAPHYSEAL DYSPLASIA SYNDROME	0.055555600000000004	2.084232235924663
DEAFNESS-LYMPHEDEMA-LEUKEMIA SYNDROME	0.055555600000000004	2.084232235924663
NEOVASCULAR GLAUCOMA	0.055555600000000004	2.084232235924663
WOLFRAM-LIKE SYNDROME	0.055555600000000004	2.084232235924663
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.0548008	2.055915045728248
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.0548008	2.055915045728248
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.053173019	1.9948469691846473
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.053173019	1.9948469691846473
15Q OVERGROWTH SYNDROME	0.053173019	1.9948469691846473
AMISH INFANTILE EPILEPSY SYNDROME	0.05301935	1.9890818998943811
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.05268975000000001	1.976716576777346
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.0526316	1.9745350126412546
STEINERT MYOTONIC DYSTROPHY	0.0526316	1.9745350126412546
MENOPAUSE, NATURAL, AGE AT, QUANTITATIVE TRAIT LOCUS 1	0.0526316	1.9745350126412546
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.0526316	1.9745350126412546
MECKEL SYNDROME, TYPE 1; MKS1	0.0526316	1.9745350126412546
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.0526316	1.9745350126412546
274210 THYMIC APLASIA WITH FETAL DEATH	0.0526316	1.9745350126412546
ISOLATED SEDOHEPTULOKINASE DEFICIENCY	0.0526316	1.9745350126412546
CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL DOMINANT	0.0526316	1.9745350126412546
CUTIS VERTICIS GYRATA, THYROID APLASIA, AND MENTAL RETARDATION	0.0526316	1.9745350126412546
ECTODERMAL DYSPLASIA WITH ADRENAL CYST	0.0526316	1.9745350126412546
BIEMOND SYNDROME II	0.0526316	1.9745350126412546
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.0526316	1.9745350126412546
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.0526316	1.9745350126412546
46,XY DISORDER OF SEX DEVELOPMENT DUE TO 5-ALPHA-REDUCTASE 2 DEFICIENCY	0.0526316	1.9745350126412546
THIOUREA TASTINGPHENYLTHIOCARBAMIDE TASTING, INCLUDED	0.0526316	1.9745350126412546
PYGMY	0.0526316	1.9745350126412546
LETHAL KNIEST-LIKE DYSPLASIA	0.0526316	1.9745350126412546
MYASTHENIA GRAVIS; MG	0.0526316	1.9745350126412546
SCALP-EAR-NIPPLE SYNDROME; SENS	0.0526316	1.9745350126412546
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.052208999000000006	1.958680650036333
JOUBERT SYNDROME	0.052208999000000006	1.958680650036333
SMITH-LEMLI-OPITZ SYNDROME	0.052208999000000006	1.958680650036333
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.05197341900000001	1.9498425953642724
CONGENITAL ANALBUMINEMIA	0.05188166	1.9464001509349758
SCHWARTZ-JAMPEL SYNDROME	0.051667580000000005	1.9383686934929403
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.051181119000000004	1.9201185495340927
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.050735659999999995	1.9034066427671283
JOUBERT SYNDROME WITH RENAL DEFECT	0.050329619000000006	1.888173547610077
JOUBERT SYNDROME WITH OCULAR DEFECT	0.050329619000000006	1.888173547610077
8P11.2 DELETION SYNDROME	0.050329619	1.888173547610077
BETA-THALASSEMIA MAJOR	0.049788200000000005	1.8678615910666847
XQ21 MICRODELETION SYNDROME	0.049641219	1.8623474297891816
LEPTIN RECEPTOR DEFICIENCY; LEPRD	0.0490998	1.8420354732457889
RHYNS SYNDROME; RHYNS	0.0490998	1.8420354732457889
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.04869253	1.8267562707401004
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.048559609999999996	1.8217696240510335
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.0485313	1.820707541837917
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.048160419	1.8067935145230836
MOSAIC TRISOMY 14	0.048160419	1.8067935145230836
EDINBURGH MALFORMATION SYNDROME	0.048160419	1.8067935145230836
2Q31.1 MICRODELETION SYNDROME	0.048160419	1.8067935145230836
SANJAD-SAKATI SYNDROME	0.048160419	1.8067935145230836
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.048160419	1.8067935145230836
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.048160419	1.8067935145230836
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.048160419	1.8067935145230836
AXENFELD-RIEGER SYNDROME	0.047619	1.786481557979691
SYMPTOMATIC FORM OF HEMOCHROMATOSIS TYPE 1	0.047619	1.786481557979691
TRIPLOIDY	0.047619	1.786481557979691
TETRAPLOIDY	0.047619	1.786481557979691
CAMPOMELIA, CUMMING TYPE	0.047619	1.786481557979691
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.047619	1.786481557979691
HUMERO-RADIAL SYNOSTOSIS	0.047619	1.786481557979691
CARTILAGE-HAIR HYPOPLASIA	0.047619	1.786481557979691
HYDROCEPHALUS-OBESITY-HYPOGONADISM SYNDROME	0.047619	1.786481557979691
DIABETIC EMBRYOPATHY	0.047619	1.786481557979691
CEREBELLAR ATAXIA-HYPOGONADISM SYNDROME	0.047619	1.786481557979691
OCULOAURICULOVERTEBRAL SPECTRUM WITH RADIAL DEFECTS	0.047619	1.786481557979691
FANCONI ANEMIA	0.047619	1.786481557979691
DISTAL TRISOMY 6P	0.047619	1.786481557979691
HOLOPROSENCEPHALY-POSTAXIAL POLYDACTYLY SYNDROME	0.047619	1.786481557979691
OCULOMAXILLOFACIAL DYSOSTOSIS	0.047619	1.786481557979691
DISTAL MONOSOMY 13Q	0.047619	1.786481557979691
NON-DISTAL TRISOMY 13Q	0.047619	1.786481557979691
XP22.3 MICRODELETION SYNDROME	0.047619	1.786481557979691
DIENCEPHALIC SYNDROME	0.047619	1.786481557979691
NON-DISTAL TRISOMY 10Q	0.047619	1.786481557979691
SEVERE CONGENITAL HYPOCHROMIC ANEMIA WITH RINGED SIDEROBLASTS	0.047619	1.786481557979691
CRANIOTELENCEPHALIC DYSPLASIA	0.047252199999999994	1.772720634073961
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.045279599999999996	1.6987162761229173
GABRIELE-DE VRIES SYNDROME	0.0451211	1.6927699663108722
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.044925509999999995	1.6854321824866583
KEUTEL SYNDROME; KTLS	0.044019719000000006	1.6514503912503038
VIRAL HEMORRHAGIC FEVER	0.044019719000000006	1.6514503912503038
LASSA FEVER	0.044019719000000006	1.6514503912503038
FAMILIAL THROMBOCYTOSIS	0.044019719000000006	1.6514503912503038
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.04396649999999999	1.6494538192510146
DESMOSTEROLOSIS	0.04396649999999999	1.6494538192510146
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.0437524	1.6414216114859745
WERNER SYNDROME	0.043478300000000004	1.6311384347069111
FAMILIAL AFIBRINOGENEMIA	0.043478300000000004	1.6311384347069111
AUTOSOMAL DOMINANT CENTRONUCLEAR MYOPATHY	0.043478300000000004	1.6311384347069111
GESTATIONAL TROPHOBLASTIC NEOPLASM	0.043478300000000004	1.6311384347069111
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.043478300000000004	1.6311384347069111
ASHERMAN SYNDROME	0.043478300000000004	1.6311384347069111
YELLOW FEVER	0.043478300000000004	1.6311384347069111
HAND-FOOT-GENITAL SYNDROME	0.043478300000000004	1.6311384347069111
PRIMARY CILIARY DYSKINESIA	0.043478300000000004	1.6311384347069111
GESTATIONAL CHORIOCARCINOMA	0.043478300000000004	1.6311384347069111
PLACENTAL INSUFFICIENCY	0.043478300000000004	1.6311384347069111
PLACENTAL SITE TROPHOBLASTIC TUMOR	0.043478300000000004	1.6311384347069111
HYDATIDIFORM MOLE	0.043478300000000004	1.6311384347069111
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.0430753	1.61601942616272
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.042760719	1.6042175581060456
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.042756550000000004	1.604061153275721
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.042756550000000004	1.604061153275721
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.042721209999999996	1.6027353325264608
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.0427032	1.6020596666607516
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.0427032	1.6020596666607516
COG2-CDG	0.041666699999999994	1.5631741769434968
DISTAL MONOSOMY 12Q	0.041666699999999994	1.5631741769434968
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.04152505	1.5578600142628902
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.04152505	1.5578600142628902
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.0414764	1.5560348535540194
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.04145493	1.5552293818085015
CHRISTIANSON SYNDROME	0.041085580000000003	1.5413727917196756
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.041085580000000003	1.5413727917196756
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.040591519	1.5228375250190518
CHROMOSOME 1P36 DELETION SYNDROME	0.040419528999999996	1.5163851223403535
16P12.1P12.3 TRIPLICATION SYNDROME	0.0400501	1.5025255684756593
AICARDI SYNDROME	0.039878109999999994	1.4960731657969608
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.039272100000000004	1.4733380035938224
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.03923768	1.4720466977027773
16P13.11 MICRODELETION SYNDROME	0.0392062	1.4708656892934198
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.0392062	1.4708656892934198
HYDROLETHALUS	0.038706359999999995	1.4521136167605952
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.038706359999999995	1.4521136167605952
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.038521299999999994	1.4451708779983423
OBESITY DUE TO CONGENITAL LEPTIN DEFICIENCY	0.0384615	1.4429274122143658
OBESITY DUE TO LEPTIN RECEPTOR GENE DEFICIENCY	0.0384615	1.4429274122143658
MENTAL RETARDATION, X-LINKED 98; MRX98	0.03838957899999999	1.4402292131734058
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.038140979	1.4309026982253024
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0380747	1.4284161653039615
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.037883259999999995	1.4212340735032172
ALSTROM SYNDROME; ALMS	0.0376653	1.413057053398275
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.037345249999999997	1.4010500095159715
MCLEOD SYNDROME; MCLDS	0.037037	1.3894856562064262
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.037037	1.3894856562064262
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.037037	1.3894856562064262
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.037037	1.3894856562064262
MYOCLONUS AND ATAXIA	0.037037	1.3894856562064262
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.037037	1.3894856562064262
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.037037	1.3894856562064262
LISSENCEPHALY 2; LIS2	0.037037	1.3894856562064262
WILLIAMS-BEUREN SYNDROME; WBS	0.03703181	1.3892909473867132
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.03623844999999999	1.359527134437286
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.03566625	1.3380603932735493
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.03566625	1.3380603932735493
JUVENILE ABSENCE EPILEPSY	0.03566625	1.3380603932735493
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.035188429	1.3201343888527213
WOLFRAM SYNDROME	0.035188429	1.3201343888527213
OCULOCEREBRORENAL SYNDROME OF LOWE	0.035188429	1.3201343888527213
COG5-CDG	0.035024219	1.3139738618228416
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.035024219	1.3139738618228416
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.035024219	1.3139738618228416
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.035024219	1.3139738618228416
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.034820050000000005	1.3063142269457726
ALPERS-HUTTENLOCHER SYNDROME	0.034820050000000005	1.3063142269457726
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.034820050000000005	1.3063142269457726
CONGENITAL MUSCULAR DYSTROPHY-RESPIRATORY FAILURE-SKIN ABNORMALITIES-JOINT HYPERLAXITY SYNDROME	0.0344828	1.2936619052794491
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.0344828	1.2936619052794491
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.0344828	1.2936619052794491
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.0344828	1.2936619052794491
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.0344828	1.2936619052794491
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.0344828	1.2936619052794491
CEREBROFACIOARTICULAR SYNDROME	0.0344828	1.2936619052794491
OROFACIODIGITAL SYNDROME TYPE 14	0.0344828	1.2936619052794491
PEHO SYNDROME	0.034427299999999994	1.2915797589414773
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.034427299999999994	1.2915797589414773
APERT SYNDROME	0.03435158	1.2887390360457798
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.034069249999999995	1.2781471013502925
DOORS SYNDROME	0.034069249999999995	1.2781471013502925
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.034069249999999995	1.2781471013502925
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.033524649	1.2577157684168563
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.033524649	1.2577157684168563
TURNPENNY-FRY SYNDROME; TPFS	0.03346038	1.2553046429574852
RAMOS-ARROYO SYNDROME	0.03346038	1.2553046429574852
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.03346038	1.2553046429574852
SSR4-CDG	0.033013618999999994	1.2385438901629164
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.033013618999999994	1.2385438901629164
ANAL SPHINCTER DYSPLASIA; ASDP	0.032983229999999995	1.2374038118734636
300270 ADRENOMYODYSTROPHY	0.032983229999999995	1.2374038118734636
TUBEROUS SCLEROSIS 2; TSC2	0.032799519	1.2305116823978763
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.032799519	1.2305116823978763
TUBEROUS SCLEROSIS-1	0.032799519	1.2305116823978763
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.03247219999999999	1.218231933619524
MICROGASTRIA-LIMB REDUCTION DEFECT SYNDROME	0.03247219999999999	1.218231933619524
MARDEN-WALKER SYNDROME	0.03247219999999999	1.218231933619524
TORIELLO-LACASSIE-DROSTE SYNDROME	0.03247219999999999	1.218231933619524
SLC35A2-CDG	0.0322581	1.2101997258544839
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.0322581	1.2101997258544839
WEST SYNDROME	0.0322581	1.2101997258544839
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.0322581	1.2101997258544839
ALG13-CDG	0.0322581	1.2101997258544839
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.0322581	1.2101997258544839
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.032122419	1.205109497074622
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.032122419	1.205109497074622
HOLMES-GANG SYNDROME	0.031581	1.1847975405312294
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.031581	1.1847975405312294
3P25.3 MICRODELETION SYNDROME	0.031226909999999997	1.1715134468949702
EPILEPSY, IDIOPATHIC GENERALIZED	0.031226909999999997	1.1715134468949702
HOLOPROSENCEPHALY 2; HPE2	0.031139849	1.168247253339472
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.030844418999999998	1.157163857075923
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.030844418999999998	1.157163857075923
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.030844418999999998	1.157163857075923
RING CHROMOSOME 22 SYNDROME	0.030844418999999998	1.157163857075923
WEAVER SYNDROME	0.030844418999999998	1.157163857075923
WALKER-WARBURG SYNDROME	0.030844418999999998	1.157163857075923
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.0306127	1.1484706522599148
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.03059843	1.1479352967960794
BRACHIAL AMELIA, CLEFT LIP, AND HOLOPROSENCEPHALY; ACLH	0.030302999999999997	1.1368519005325306
NEU-LAXOVA SYNDROME	0.030302999999999997	1.1368519005325306
HYDROCEPHALUS DUE TO CONGENITAL STENOSIS OF AQUEDUCT OF SYLVIUS	0.030302999999999997	1.1368519005325306
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.030302999999999997	1.1368519005325306
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.030302999999999997	1.1368519005325306
HYDROLETHALUS SYNDROME 1	0.030302999999999997	1.1368519005325306
DISTAL 16P11.2 MICRODELETION SYNDROME	0.029953219	1.1237294639876283
PITT-HOPKINS-LIKE SYNDROME	0.029953219	1.1237294639876283
7Q11.23 MICRODUPLICATION SYNDROME	0.029953219	1.1237294639876283
16P13.2 MICRODELETION SYNDROME	0.029953219	1.1237294639876283
QAZI-MARKOUIZOS SYNDROME	0.029953219	1.1237294639876283
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.029953219	1.1237294639876283
FG SYNDROME TYPE 1	0.029465409000000005	1.105428710742116
CURRARINO SYNDROME	0.0294118	1.1034175074442358
AL AMYLOIDOSIS	0.0294118	1.1034175074442358
CURRY-JONES SYNDROME	0.0294118	1.1034175074442358
VARIANT ABETA2M AMYLOIDOSIS	0.0294118	1.1034175074442358
HEREDITARY LATE-ONSET PARKINSON DISEASE	0.0294118	1.1034175074442358
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.029165418999999998	1.094174240833501
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.028623999999999997	1.0738622842901084
FEBRILE CONVULSIONS, FAMILIAL, 9	0.028623999999999997	1.0738622842901084
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.027795809999999997	1.0427917838280407
EPILEPSY, PYRIDOXINE-DEPENDENT	0.027795809999999997	1.0427917838280407
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.027777800000000002	1.0421161179623315
PERIVENTRICULAR NODULAR HETEROTOPIA	0.027777800000000002	1.0421161179623315
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.027777800000000002	1.0421161179623315
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.027777800000000002	1.0421161179623315
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.027777800000000002	1.0421161179623315
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.027777800000000002	1.0421161179623315
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.027777800000000002	1.0421161179623315
PROTEUS SYNDROME	0.027568419	1.0342609489102441
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.027568419	1.0342609489102441
CENTRAL DIABETES INSIPIDUS	0.027568419	1.0342609489102441
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.027568419	1.0342609489102441
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.027568419	1.0342609489102441
FABRY DISEASE	0.027568419	1.0342609489102441
HOLOPROSENCEPHALY 1; HPE1	0.027568419	1.0342609489102441
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.027568419	1.0342609489102441
ACQUIRED CENTRAL DIABETES INSIPIDUS	0.027027	1.0139489923668517
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.027027	1.0139489923668517
BENIGN OCCIPITAL EPILEPSY	0.027027	1.0139489923668517
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.027027	1.0139489923668517
SARCOIDOSIS	0.027027	1.0139489923668517
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.027027	1.0139489923668517
HEREDITARY CENTRAL DIABETES INSIPIDUS	0.027027	1.0139489923668517
APNEA, OBSTRUCTIVE SLEEP	0.027027	1.0139489923668517
CHROMOSOME 17Q12 DELETION SYNDROME	0.027027	1.0139489923668517
GROWTH HORMONE INSENSITIVITY SYNDROME	0.027027	1.0139489923668517
GIANT CELL ARTERITIS	0.027027	1.0139489923668517
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.027027	1.0139489923668517
14Q22Q23 MICRODELETION SYNDROME	0.027027	1.0139489923668517
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.027027	1.0139489923668517
ERDHEIM-CHESTER DISEASE	0.027027	1.0139489923668517
XANTHOMA DISSEMINATUM	0.027027	1.0139489923668517
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.025563699999999998	0.9590516097298435
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.02488188	0.9334723481774861
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.024184659999999997	0.9073153379115292
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.023543919	0.8832772022946229
CHROMOSOME 19P13.13 DELETION SYNDROME	0.023231249000000002	0.8715470276010445
TEMPLE SYNDROME	0.023090239999999998	0.8662569127727372
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.0230025	0.8629652457512303
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.022922759999999997	0.8599737079315932
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.02258513	0.847307130128181
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.02206686	0.8278636349465492
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.02196765	0.8241416576818613
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.02196765	0.8241416576818613
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.02196765	0.8241416576818613
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.02196765	0.8241416576818613
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.02196765	0.8241416576818613
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.021374719	0.8018971692076293
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.021374719	0.8018971692076293
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.02099778	0.7877558690546799
MELANOMA, CUTANEOUS MALIGNANT	0.0208333	0.7815852126642369
OCULOCEREBRAL SYNDROME WITH HYPOPIGMENTATION	0.0208333	0.7815852126642369
MYDRIATIC RESPONSE TO PHARMACOLOGIC AGENTS	0.0208333	0.7815852126642369
CRANDALL SYNDROME	0.0208333	0.7815852126642369
MELKERSSON-ROSENTHAL SYNDROME	0.0208333	0.7815852126642369
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.0208333	0.7815852126642369
MYELINATED OPTIC NERVE FIBERS	0.0208333	0.7815852126642369
CARNEY COMPLEX, TYPE 1; CNC1	0.0208333	0.7815852126642369
LEVATOR-MEDIAL RECTUS SYNKINESIS	0.0208333	0.7815852126642369
PREPAPILLARY VASCULAR LOOPS	0.0208333	0.7815852126642369
HYPERCALCEMIA, INFANTILE, 1	0.0208333	0.7815852126642369
BLEPHAROCHALASIS AND DOUBLE LIP	0.0208333	0.7815852126642369
%271530 BRACHYOLMIA TYPE 1, HOBAEK TYPE;;BRACHYOLMIA, RECESSIVE TYPE OF HOBAEK;;SPONDYLODYSPLASIA WITH PURE BRACHYOLMIA	0.0208333	0.7815852126642369
DEAFNESS, AUTOSOMAL RECESSIVE 12; DFNB12	0.0208333	0.7815852126642369
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.0208333	0.7815852126642369
DERMOIDS OF CORNEA	0.0208333	0.7815852126642369
SCHOPF-SCHULZ-PASSARGE SYNDROME; SSPS	0.0208333	0.7815852126642369
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1	0.0208333	0.7815852126642369
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 5	0.0208333	0.7815852126642369
INFANTILE MYOFIBROMATOSIS	0.0208333	0.7815852126642369
GAUCHER DISEASE, TYPE I	0.0208333	0.7815852126642369
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.0208333	0.7815852126642369
AGNATHIA-OTOCEPHALY COMPLEX	0.0208333	0.7815852126642369
ACROMEGALOID CHANGES, CUTIS VERTICIS GYRATA, AND CORNEAL LEUKOMA	0.0208333	0.7815852126642369
IMINOGLYCINURIA	0.0208333	0.7815852126642369
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.0208333	0.7815852126642369
UNIQUE GREEN PHENOMENON	0.0208333	0.7815852126642369
LARYNGOONYCHOCUTANEOUS SYNDROME	0.0208333	0.7815852126642369
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.0208333	0.7815852126642369
OCULAR CICATRICIAL PEMPHIGOID	0.0208333	0.7815852126642369
OSTEOGENESIS IMPERFECTA, TYPE V	0.0208333	0.7815852126642369
611426 TENTED EYEBROWS	0.0208333	0.7815852126642369
%611694 DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA	0.0208333	0.7815852126642369
PUPIL, EGG-SHAPED	0.0208333	0.7815852126642369
%300700 ALBINISM-DEAFNESS SYNDROME; ADFN;;ALDS	0.0208333	0.7815852126642369
SETTING-SUN PHENOMENON, FAMILIAL BENIGN	0.0208333	0.7815852126642369
SEA-BLUE HISTIOCYTE DISEASE	0.0208333	0.7815852126642369
STICKLER SYNDROME, TYPE III	0.0208333	0.7815852126642369
ERYTHERMALGIA, PRIMARY	0.02081283	0.7808172570689526
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.020740849999999998	0.7781168445751291
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.020740849999999998	0.7781168445751291
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.020740849999999998	0.7781168445751291
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.020740849999999998	0.7781168445751291
SALT-AND-PEPPER SYNDROME	0.02070575	0.7768000277019254
GAUCHER DISEASE	0.02035009	0.7634570337097992
16Q24.3 MICRODELETION SYNDROME	0.019659819000000002	0.7375607231718165
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.019659819000000002	0.7375607231718165
5Q14.3 MICRODELETION SYNDROME	0.019659819000000002	0.7375607231718165
19P13.13 MICRODELETION SYNDROME	0.019659819000000002	0.7375607231718165
2P15P16.1 MICRODELETION SYNDROME	0.0191184	0.7172487666284241
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.0191184	0.7172487666284241
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.01853655	0.6954199946149318
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.01853655	0.6954199946149318
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.01853655	0.6954199946149318
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.018470709999999998	0.6929499312835434
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.018288599	0.6861178276483298
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.017747179999999998	0.6658058711049373
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.01768055	0.6633061700148644
PHACE ASSOCIATION	0.017490619000000002	0.656180690084823
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.017490619000000002	0.656180690084823
PHACE SYNDROME	0.017490619000000002	0.656180690084823
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.017490619000000002	0.656180690084823
HYDRANENCEPHALY	0.017490619000000002	0.656180690084823
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.017490619000000002	0.656180690084823
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.017490619000000002	0.656180690084823
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.017490619000000002	0.656180690084823
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.017490619000000002	0.656180690084823
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.017490619000000002	0.656180690084823
8Q24.3 MICRODELETION SYNDROME	0.017490619000000002	0.656180690084823
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.017490619000000002	0.656180690084823
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.017490619000000002	0.656180690084823
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.017490619000000002	0.656180690084823
19P13.3 MICRODUPLICATION SYNDROME	0.01727003	0.647905040020916
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.01727003	0.647905040020916
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	0.6468309526397246
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.6468309526397246
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.6468309526397246
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.6468309526397246
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.6468309526397246
DIASTEMATOMYELIA	0.0172414	0.6468309526397246
CERVICAL RIB	0.0172414	0.6468309526397246
JUMPING FRENCHMAN OF MAINE	0.0172414	0.6468309526397246
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.6468309526397246
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.6468309526397246
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.6468309526397246
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.6468309526397246
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.6468309526397246
MYOPATHY, CONGENITAL	0.0172414	0.6468309526397246
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	0.6468309526397246
THUMBS, CONGENITAL CLASPED	0.0172414	0.6468309526397246
MOTION SICKNESS	0.0172414	0.6468309526397246
ALCOHOL DEPENDENCE	0.0172414	0.6468309526397246
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.6468309526397246
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	0.6468309526397246
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.6468309526397246
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.6468309526397246
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.6468309526397246
SICKLE CELL ANEMIA	0.0172414	0.6468309526397246
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.6468309526397246
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.6468309526397246
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.6468309526397246
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.6468309526397246
TRANSSEXUALITY	0.0172414	0.6468309526397246
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	0.6468309526397246
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.6468309526397246
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	0.6468309526397246
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.6468309526397246
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.6468309526397246
MOSAIC TRISOMY 15	0.0172414	0.6468309526397246
RHEUMATOID ARTHRITIS	0.0172414	0.6468309526397246
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.6468309526397246
PALMOMENTAL REFLEX	0.0172414	0.6468309526397246
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.6468309526397246
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	0.6468309526397246
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.6468309526397246
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.6468309526397246
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	0.6468309526397246
CARDIAC ARRHYTHMIA	0.0172414	0.6468309526397246
269800 SENILE PLAQUE FORMATION	0.0172414	0.6468309526397246
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	0.6468309526397246
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.6468309526397246
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.6468309526397246
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.6468309526397246
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.6468309526397246
CONGENITAL TRACHEAL STENOSIS	0.0172414	0.6468309526397246
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.01723493	0.6465882231477124
HAREL-YOON SYNDROME; HAYOS	0.017094599999999998	0.6413235817854138
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.017094599999999998	0.6413235817854138
%300843 BORNHOLM EYE DISEASE; BED;;MYOPIA, HIGH, WITH NONPROGRESSIVE CONE DYSFUNCTION	0.0169492	0.6358687335414305
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.0169492	0.6358687335414305
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.0169492	0.6358687335414305
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.0169492	0.6358687335414305
PERMANENT NEONATAL DIABETES MELLITUS-PANCREATIC AND CEREBELLAR AGENESIS SYNDROME	0.0169492	0.6358687335414305
MICROPHTHALMIA, SYNDROMIC 3	0.0169492	0.6358687335414305
ANIRIDIA-INTELLECTUAL DISABILITY SYNDROME	0.0169492	0.6358687335414305
BRESEK SYNDROME	0.0169492	0.6358687335414305
MICROPHTHALMIA, ISOLATED 8	0.0169492	0.6358687335414305
STROMME SYNDROME; STROMS	0.0169492	0.6358687335414305
CRANIOSYNOSTOSIS 4; CRS4	0.0169492	0.6358687335414305
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.0169492	0.6358687335414305
ANIRIDIA	0.0169492	0.6358687335414305
TRICHOTHIODYSTROPHY 5, NONPHOTOSENSITIVE	0.0169492	0.6358687335414305
231970 GLUTEAL MUSCLES, ABSENCE OF	0.0169492	0.6358687335414305
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.0169492	0.6358687335414305
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.0169492	0.6358687335414305
OVERGROWTH-MACROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.0169492	0.6358687335414305
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.0169492	0.6358687335414305
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.0169492	0.6358687335414305
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.0169492	0.6358687335414305
JACOBSEN SYNDROME	0.016564789	0.6214471127139345
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.016564789	0.6214471127139345
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.016301509999999998	0.6115698981965498
TRANSIENT NEONATAL DIABETES MELLITUS	0.016301509999999998	0.6115698981965498
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.016301509999999998	0.6115698981965498
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.016301509999999998	0.6115698981965498
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.016301509999999998	0.6115698981965498
PERMANENT NEONATAL DIABETES MELLITUS	0.016301509999999998	0.6115698981965498
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.015867799999999998	0.5952987686786816
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.015867799999999998	0.5952987686786816
WITTEVEEN-KOLK SYNDROME	0.015228299	0.571307153088065
COHEN SYNDROME	0.015228298999999999	0.571307153088065
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.014925399999999998	0.5599435486984203
MYOCLONIC-ATONIC EPILEPSY	0.014925399999999998	0.5599435486984203
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.014925399999999998	0.5599435486984203
NIEMANN-PICK DISEASE TYPE B	0.014925399999999998	0.5599435486984203
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.014925399999999998	0.5599435486984203
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.014925399999999998	0.5599435486984203
MENTAL RETARDATION, X-LINKED 41	0.014925399999999998	0.5599435486984203
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.014925399999999998	0.5599435486984203
HYPOTONIA-CYSTINURIA SYNDROME	0.01468688	0.5509951965446725
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.014204918999999998	0.5329138752618767
SILVER-RUSSELL SYNDROME	0.01414399	0.5306280537442862
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.013698599999999998	0.513918735591688
EPILEPSY, HOT WATER, 1	0.013698599999999998	0.513918735591688
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.013698599999999998	0.513918735591688
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.013698599999999998	0.513918735591688
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.013698599999999998	0.513918735591688
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.013698599999999998	0.513918735591688
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.013698599999999998	0.513918735591688
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.013698599999999998	0.513918735591688
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.013698599999999998	0.513918735591688
AYM-GRIPP SYNDROME	0.013698599999999998	0.513918735591688
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.013698599999999998	0.513918735591688
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.013698599999999998	0.513918735591688
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.013698599999999998	0.513918735591688
MENTAL RETARDATION, X-LINKED 77	0.013698599999999998	0.513918735591688
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.013698599999999998	0.513918735591688
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.013698599999999998	0.513918735591688
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.013698599999999998	0.513918735591688
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.013663499999999999	0.5126019187184843
PEHO-LIKE SYNDROME; PEHOL	0.013663499999999999	0.5126019187184843
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.013663499999999999	0.5126019187184843
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.013663499999999999	0.5126019187184843
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.013663499999999999	0.5126019187184843
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.013663499999999999	0.5126019187184843
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.013663499999999999	0.5126019187184843
HELSMOORTEL-VAN DER AA SYNDROME	0.013348918999999999	0.5008000506618092
WIEDEMANN-STEINER SYNDROME	0.013348918999999999	0.5008000506618092
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.013348918999999999	0.5008000506618092
CORNELIA DE LANGE SYNDROME	0.012993359000000001	0.4874608082847065
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.012993359000000001	0.4874608082847065
ZELLWEGER SYNDROME	0.012993359000000001	0.4874608082847065
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.0128075	0.4804880941184168
LYSINURIC PROTEIN INTOLERANCE	0.0128075	0.4804880941184168
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.0128075	0.4804880941184168
MEIER-GORLIN SYNDROME 6; MGORS6	0.0128075	0.4804880941184168
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.0128075	0.4804880941184168
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.0128075	0.4804880941184168
KAGAMI-OGATA SYNDROME	0.012516209	0.46955997720068526
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.012516209	0.46955997720068526
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.012516209	0.46955997720068526
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.012516209	0.46955997720068526
BECKWITH-WIEDEMANN SYNDROME	0.012451940000000002	0.46714885174131404
CARDIOFACIOCUTANEOUS SYNDROME	0.012451940000000002	0.46714885174131404
GMS SYNDROME	0.012451940000000002	0.46714885174131404
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.012451940000000002	0.46714885174131404
HYPERPROLINEMIA, TYPE I	0.012035718999999999	0.4515338421748833
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.01197479	0.4492480206572928
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.01197479	0.4492480206572928
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.011494299999999999	0.4312218856314908
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.011494299999999999	0.4312218856314908
PERLMAN SYNDROME	0.011494299999999999	0.4312218856314908
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.011494299999999999	0.4312218856314908
BETA-UREIDOPROPIONASE DEFICIENCY	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.011494299999999999	0.4312218856314908
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.011494299999999999	0.4312218856314908
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.011494299999999999	0.4312218856314908
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.011494299999999999	0.4312218856314908
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.011494299999999999	0.4312218856314908
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.011494299999999999	0.4312218856314908
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.011494299999999999	0.4312218856314908
X-LINKED SPASTICITY-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.011494299999999999	0.4312218856314908
FUMARASE DEFICIENCY; FMRD	0.011494299999999999	0.4312218856314908
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.011494299999999999	0.4312218856314908
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.011494299999999999	0.4312218856314908
PYRIDOXINE-DEPENDENT EPILEPSY	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.011494299999999999	0.4312218856314908
RING CHROMOSOME 14 SYNDROME	0.011494299999999999	0.4312218856314908
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.011494299999999999	0.4312218856314908
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.011494299999999999	0.4312218856314908
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.01142846	0.42875182230010245
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.01142846	0.42875182230010245
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.01142846	0.42875182230010245
KRABBE DISEASE	0.01142846	0.42875182230010245
SRD5A3-CDG	0.011179719	0.4194200175748158
PRADER-WILLI SYNDROME; PWS	0.011179719	0.4194200175748158
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.011179719	0.4194200175748158
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.011179719	0.4194200175748158
MEHMO SYNDROME; MEHMO	0.011179719	0.4194200175748158
CHROMOSOME 18Q DELETION SYNDROME	0.011179719	0.4194200175748158
PRADER-WILLI SYNDROME	0.011179719	0.4194200175748158
DISTAL MONOSOMY 10Q	0.011113979	0.4169537058584507
SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI	0.0106383	0.39910806103142327
EEC SYNDROME	0.0106383	0.39910806103142327
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.0106383	0.39910806103142327
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.0106383	0.39910806103142327
OLIVER-MCFARLANE SYNDROME	0.0106383	0.39910806103142327
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.0106383	0.39910806103142327
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.0106383	0.39910806103142327
208080 ARTHROGRYPOSIS, DISTAL, WITH HYPOPITUITARISM, MENTAL RETARDATION,AND FACIAL ANOMALIES	0.0106383	0.39910806103142327
FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW	0.0106383	0.39910806103142327
ISOLATED GROWTH HORMONE DEFICIENCY, TYPE V; IGHD5	0.0106383	0.39910806103142327
ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS	0.0106383	0.39910806103142327
ACROOTOOCULAR SYNDROME	0.0106383	0.39910806103142327
AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1	0.0106383	0.39910806103142327
WOODHOUSE-SAKATI SYNDROME	0.0106383	0.39910806103142327
SILVER-RUSSELL SYNDROME; SRS	0.0106383	0.39910806103142327
RITSCHER-SCHINZEL SYNDROME 1	0.0106383	0.39910806103142327
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.0106383	0.39910806103142327
GROWTH HORMONE DEFICIENCY, ISOLATED PARTIAL; GHDP	0.0106383	0.39910806103142327
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.0106383	0.39910806103142327
CATARACT-GROWTH HORMONE DEFICIENCY-SENSORY NEUROPATHY-SENSORINEURAL HEARING LOSS-SKELETAL DYSPLASIA SYNDROME	0.0106383	0.39910806103142327
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.0106383	0.39910806103142327
BOOMERANG DYSPLASIA	0.0106383	0.39910806103142327
ENCEPHALOPATHY WITH INTRACRANIAL CALCIFICATION, GROWTH HORMONE DEFICIENCY, MICROCEPHALY, AND RETINAL DEGENERATION	0.0106383	0.39910806103142327
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.0106383	0.39910806103142327
BONNEMANN-MEINECKE-REICH SYNDROME	0.0106383	0.39910806103142327
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.0106383	0.39910806103142327
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.0106383	0.39910806103142327
TYSHCHENKO SYNDROME	0.01057256	0.39664174931505825
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.01057256	0.39664174931505825
TEMPLE SYNDROME	0.01057256	0.39664174931505825
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.01057256	0.39664174931505825
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.009800679	0.36768374575650137
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.009800679	0.36768374575650137
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.009800679	0.36768374575650137
MERRF	0.00925926	0.3473717892131089
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.00925926	0.3473717892131089
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.00925926	0.3473717892131089
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.00925926	0.3473717892131089
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.00925926	0.3473717892131089
CARNOSINASE DEFICIENCY	0.00925926	0.3473717892131089
CARNOSINEMIA	0.00925926	0.3473717892131089
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.00925926	0.3473717892131089
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.00925926	0.3473717892131089
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.00925926	0.3473717892131089
MICROHYDRANENCEPHALY; MHAC	0.00925926	0.3473717892131089
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.00925926	0.3473717892131089
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.00925926	0.3473717892131089
BIOTINIDASE DEFICIENCY	0.00925926	0.3473717892131089
GAUCHER DISEASE TYPE 2	0.00925926	0.3473717892131089
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.00925926	0.3473717892131089
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.00925926	0.3473717892131089
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.00925926	0.3473717892131089
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.00925926	0.3473717892131089
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.00925926	0.3473717892131089
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.00925926	0.3473717892131089
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.00925926	0.3473717892131089
GLYCINE ENCEPHALOPATHY	0.00925926	0.3473717892131089
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.00925926	0.3473717892131089
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.00925926	0.3473717892131089
GAUCHER DISEASE TYPE 3	0.00925926	0.3473717892131089
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.00925926	0.3473717892131089
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.00925926	0.3473717892131089
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.00925926	0.3473717892131089
PAINE SYNDROME	0.00925926	0.3473717892131089
XQ12-Q13.3 DUPLICATION SYNDROME	0.00925926	0.3473717892131089
ROIFMAN-CHITAYAT SYNDROME	0.00925926	0.3473717892131089
HYDROXYLYSINURIA	0.00925926	0.3473717892131089
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.00925926	0.3473717892131089
AMISH LETHAL MICROCEPHALY	0.00921145	0.3455781420704346
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.00921145	0.3455781420704346
X SMALL RINGS	0.00921145	0.3455781420704346
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.00921145	0.3455781420704346
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.008944779	0.3355736727714572
CONGENITAL TOXOPLASMOSIS	0.008944779	0.3355736727714572
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.008944779	0.3355736727714572
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.008944779	0.3355736727714572
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.008944779	0.3355736727714572
GAUCHER DISEASE, PERINATAL LETHAL	0.008944779	0.3355736727714572
ADAMS-OLIVER SYNDROME	0.008944779	0.3355736727714572
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.008944779	0.3355736727714572
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.008944779	0.3355736727714572
GALLOWAY-MOWAT SYNDROME	0.008944779	0.3355736727714572
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.008944779	0.3355736727714572
KAGAMI-OGATA SYNDROME	0.008944779	0.3355736727714572
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.008944779	0.3355736727714572
PELIZAEUS-MERZBACHER DISEASE	0.008944779	0.3355736727714572
INFANTILE SIALIC ACID STORAGE DISEASE	0.008944779	0.3355736727714572
FATCO SYNDROME	0.00840336	0.31526171622806476
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.00840336	0.31526171622806476
YUNIS-VARON SYNDROME	0.00840336	0.31526171622806476
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.00840336	0.31526171622806476
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.00840336	0.31526171622806476
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.00840336	0.31526171622806476
ROIFMAN SYNDROME; RFMN	0.00840336	0.31526171622806476
INTERMEDIATE NEMALINE MYOPATHY	0.00840336	0.31526171622806476
CLASSICAL EHLERS-DANLOS SYNDROME	0.00840336	0.31526171622806476
DISTAL MONOSOMY 17Q	0.00840336	0.31526171622806476
NEMALINE MYOPATHY 10	0.00840336	0.31526171622806476
ROBERTS SYNDROME	0.00840336	0.31526171622806476
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.31526171622806476
DIAMOND-BLACKFAN ANEMIA 1	0.00840336	0.31526171622806476
RENAL TUBULAR DYSGENESIS	0.00840336	0.31526171622806476
ATELOSTEOGENESIS, TYPE I; AO1	0.00840336	0.31526171622806476
PTOSIS-VOCAL CORD PARALYSIS SYNDROME	0.00840336	0.31526171622806476
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.00840336	0.31526171622806476
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.00840336	0.31526171622806476
CONGENITAL HERPES SIMPLEX VIRUS INFECTION	0.00840336	0.31526171622806476
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00840336	0.31526171622806476
CONGENITAL ENTEROVIRUS INFECTION	0.00840336	0.31526171622806476
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.00840336	0.31526171622806476
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.00840336	0.31526171622806476
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.00840336	0.31526171622806476
CINCA SYNDROME	0.00840336	0.31526171622806476
VASCULAR EHLERS-DANLOS SYNDROME	0.00840336	0.31526171622806476
CONGENITAL PULMONARY AIRWAY MALFORMATION	0.00840336	0.31526171622806476
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.31526171622806476
COSTELLO SYNDROME; CSTLO	0.00840336	0.31526171622806476
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.00840336	0.31526171622806476
INDOMETHACIN EMBRYOFETOPATHY	0.00840336	0.31526171622806476
PULMONARY ATRESIA-INTACT VENTRICULAR SEPTUM SYNDROME	0.00840336	0.31526171622806476
RETINOPATHY OF PREMATURITY	0.00840336	0.31526171622806476
ICHTHYOSIS-PREMATURITY SYNDROME	0.00840336	0.31526171622806476
BRONCHOPULMONARY DYSPLASIA	0.00840336	0.31526171622806476
FIBULAR APLASIA-ECTRODACTYLY SYNDROME	0.00840336	0.31526171622806476
VELO-FACIAL-SKELETAL SYNDROME	0.00840336	0.31526171622806476
FIBULO-ULNAR HYPOPLASIA-RENAL ANOMALIES SYNDROME	0.00840336	0.31526171622806476
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.00840336	0.31526171622806476
SCHISIS ASSOCIATION	0.00840336	0.31526171622806476
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00840336	0.31526171622806476
EBSTEIN MALFORMATION	0.00840336	0.31526171622806476
VACTERL/VATER ASSOCIATION	0.00840336	0.31526171622806476
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.00840336	0.31526171622806476
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00840336	0.31526171622806476
HEC SYNDROME	0.00840336	0.31526171622806476
DIETHYLSTILBESTROL SYNDROME	0.00840336	0.31526171622806476
OMPHALOCELE	0.00840336	0.31526171622806476
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.00840336	0.31526171622806476
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.00840336	0.31526171622806476
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00840336	0.31526171622806476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.00840336	0.31526171622806476
PEDIATRIC-ONSET GRAVES DISEASE	0.00840336	0.31526171622806476
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.00840336	0.31526171622806476
BLOMSTRAND LETHAL CHONDRODYSPLASIA	0.00840336	0.31526171622806476
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.00840336	0.31526171622806476
PEMPHIGOID GESTATIONIS	0.00840336	0.31526171622806476
1P36 DELETION SYNDROME	0.008161429000000001	0.3061853964858698
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.008161429000000001	0.3061853964858698
22Q11.2 DELETION SYNDROME	0.008161429000000001	0.3061853964858698
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.008161429	0.30618539648586973
PROPIONIC ACIDEMIA	0.008161429	0.30618539648586973
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.008161429	0.30618539648586973
ANGELMAN SYNDROME	0.008161429	0.30618539648586973
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.008161429	0.30618539648586973
48,XXYY SYNDROME	0.008161429	0.30618539648586973
XQ28 (MECP2) DUPLICATION	0.008161429	0.30618539648586973
SMITH-MAGENIS SYNDROME	0.008161429	0.30618539648586973
RUBINSTEIN-TAYBI SYNDROME	0.008161429	0.30618539648586973
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.00762001	0.28587343994247727
FLOATING-HARBOR SYNDROME	0.00762001	0.28587343994247727
NIEMANN-PICK DISEASE, TYPE A	0.00762001	0.28587343994247727
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.00762001	0.28587343994247727
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.00762001	0.28587343994247727
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.00762001	0.28587343994247727
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.00762001	0.28587343994247727
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.00762001	0.28587343994247727
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.0075836689999999995	0.2845100655268335
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.0075836689999999995	0.2845100655268335
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.00704225	0.26419810898344104
TUBULAR RENAL DISEASE-CARDIOMYOPATHY SYNDROME	0.00704225	0.26419810898344104
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.00704225	0.26419810898344104
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.00704225	0.26419810898344104
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.00704225	0.26419810898344104
1Q44 MICRODELETION SYNDROME	0.00704225	0.26419810898344104
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.00704225	0.26419810898344104
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.00704225	0.26419810898344104
PELGER-HUET ANOMALY; PHA	0.00704225	0.26419810898344104
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.00704225	0.26419810898344104
OLIVER SYNDROME	0.00704225	0.26419810898344104
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00704225	0.26419810898344104
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.00704225	0.26419810898344104
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.00704225	0.26419810898344104
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.00704225	0.26419810898344104
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.00704225	0.26419810898344104
OROFACIODIGITAL SYNDROME TYPE 2	0.00704225	0.26419810898344104
MYOCLONIC EPILEPSY, JUVENILE, 2	0.00704225	0.26419810898344104
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.00704225	0.26419810898344104
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.00704225	0.26419810898344104
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.00704225	0.26419810898344104
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00704225	0.26419810898344104
EPILEPSY, BENIGN NEONATAL, 3	0.00704225	0.26419810898344104
W SYNDROME	0.00704225	0.26419810898344104
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.00704225	0.26419810898344104
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.00704225	0.26419810898344104
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.00704225	0.26419810898344104
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.00704225	0.26419810898344104
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.00704225	0.26419810898344104
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.00704225	0.26419810898344104
SARCOSINEMIA	0.00704225	0.26419810898344104
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.00704225	0.26419810898344104
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.00704225	0.26419810898344104
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.00704225	0.26419810898344104
HALLERMANN-STREIFF SYNDROME; HSS	0.00704225	0.26419810898344104
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.006282049	0.235678294059614
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.006282049	0.235678294059614
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.006282049	0.235678294059614
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.006282049	0.235678294059614
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.006282049	0.235678294059614
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.006282049	0.235678294059614
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.006282049	0.235678294059614
PITT-HOPKINS SYNDROME	0.006282049	0.235678294059614
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.006282049	0.235678294059614
DESANTO-SHINAWI SYNDROME	0.006282049	0.235678294059614
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.006282049	0.235678294059614
EMANUEL SYNDROME	0.006282049	0.235678294059614
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.006282049	0.235678294059614
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.006282049	0.235678294059614
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.006282049	0.235678294059614
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.006282049	0.235678294059614
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.006282049	0.235678294059614
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.006282049	0.235678294059614
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.006282049	0.235678294059614
SCHAAF-YANG SYNDROME; SHFYNG	0.006282049	0.235678294059614
PRADER-WILLI-LIKE SYNDROME	0.006282049	0.235678294059614
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.006282049	0.235678294059614
PERMANENT CONGENITAL HYPOTHYROIDISM	0.00574063	0.21536633751622153
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.00574063	0.21536633751622153
INFANTILE DYSTONIA-PARKINSONISM	0.00574063	0.21536633751622153
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED SEVERE	0.00574063	0.21536633751622153
COFFIN-SIRIS SYNDROME 7; CSS7	0.00574063	0.21536633751622153
AU-KLINE SYNDROME; AUKS	0.00574063	0.21536633751622153
HYPOTHYROIDISM DUE TO TSH RECEPTOR MUTATIONS	0.00574063	0.21536633751622153
ATHYREOSIS	0.00574063	0.21536633751622153
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.00574063	0.21536633751622153
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.00574063	0.21536633751622153
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.00574063	0.21536633751622153
PERIPHERAL HYPOTHYROIDISM	0.00574063	0.21536633751622153
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.00574063	0.21536633751622153
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.00574063	0.21536633751622153
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.00574063	0.21536633751622153
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.00574063	0.21536633751622153
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.00574063	0.21536633751622153
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00574063	0.21536633751622153
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.00574063	0.21536633751622153
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.00574063	0.21536633751622153
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.004589999000000001	0.1721990920566418
FAMILIAL DYSAUTONOMIA	0.004589999000000001	0.1721990920566418
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.004589999000000001	0.1721990920566418
VICI SYNDROME	0.004589999000000001	0.1721990920566418
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.004589999000000001	0.1721990920566418
KABUKI SYNDROME 1	0.004589999000000001	0.1721990920566418
COFFIN-SIRIS SYNDROME	0.004589999000000001	0.1721990920566418
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.004589999000000001	0.1721990920566418
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.004589999000000001	0.1721990920566418
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.004589999000000001	0.1721990920566418
COFS SYNDROME	0.004589999000000001	0.1721990920566418
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.004589999000000001	0.1721990920566418
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.004589999000000001	0.1721990920566418
21Q22.11Q22.12 MICRODELETION SYNDROME	0.004589999000000001	0.1721990920566418
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.004589999000000001	0.1721990920566418
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.004589999000000001	0.1721990920566418
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.004589999000000001	0.1721990920566418
GALACTOSEMIA	0.004589999000000001	0.1721990920566418
SOTOS SYNDROME	0.004589999000000001	0.1721990920566418
LISSENCEPHALY, X-LINKED, 2	0.004589999000000001	0.1721990920566418
ACROCARDIOFACIAL SYNDROME	0.004589999000000001	0.1721990920566418
PYRUVATE DEHYDROGENASE DEFICIENCY	0.004589999000000001	0.1721990920566418
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.004589999000000001	0.1721990920566418
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.004589999000000001	0.1721990920566418
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.004589999000000001	0.1721990920566418
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.004589999000000001	0.1721990920566418
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.004589999000000001	0.1721990920566418
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.004589999000000001	0.1721990920566418
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.004589999000000001	0.1721990920566418
FOLATE MALABSORPTION, HEREDITARY	0.004589999000000001	0.1721990920566418
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.004589999000000001	0.1721990920566418
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.004589999000000001	0.1721990920566418
SYSTEMIC SCLEROSIS	0.004589999000000001	0.1721990920566418
OROFACIODIGITAL SYNDROME TYPE 6	0.004589999000000001	0.1721990920566418
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.004589999000000001	0.1721990920566418
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.004589999000000001	0.1721990920566418
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.004589999000000001	0.1721990920566418
COFFIN-SIRIS SYNDROME 1; CSS1	0.004589999000000001	0.1721990920566418
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.004589999000000001	0.1721990920566418
NON-DISTAL MONOSOMY 20Q	0.004589999000000001	0.1721990920566418
COFFIN-LOWRY SYNDROME	0.004589999000000001	0.1721990920566418
OHDO SYNDROME	0.004589999000000001	0.1721990920566418
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.004589999000000001	0.1721990920566418
COHEN SYNDROME	0.004589999000000001	0.1721990920566418
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.004589999000000001	0.1721990920566418
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.004589999000000001	0.1721990920566418
MENKES DISEASE	0.004589999000000001	0.1721990920566418
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.004589999000000001	0.1721990920566418
MALAN OVERGROWTH SYNDROME	0.004589999000000001	0.1721990920566418
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.004589999000000001	0.1721990920566418
CANAVAN DISEASE	0.004589999000000001	0.1721990920566418
KOOLEN-DE VRIES SYNDROME; KDVS	0.004589999000000001	0.1721990920566418
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.004589999000000001	0.1721990920566418
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.004589999000000001	0.1721990920566418
CHROMOSOME 16P13.3 DELETION SYNDROME	0.004589999000000001	0.1721990920566418
SCLERODERMA	0.004589999000000001	0.1721990920566418
BOWEN-CONRADI SYNDROME	0.004589999000000001	0.1721990920566418
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.004589999000000001	0.1721990920566418
CORNELIA DE LANGE SYNDROME 3	0.004589999000000001	0.1721990920566418
HYPOADRENOCORTICISM, FAMILIAL	0.004589999000000001	0.1721990920566418
POTOCKI-LUPSKI SYNDROME	0.004589999000000001	0.1721990920566418
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.004589999000000001	0.1721990920566418
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.004589999000000001	0.1721990920566418
METHYLMALONIC ACIDURIA, CBLA TYPE	0.004589999000000001	0.1721990920566418
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.004589999000000001	0.1721990920566418
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.004589999000000001	0.1721990920566418
2Q33.1 DELETION SYNDROME	0.004589999000000001	0.1721990920566418
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.004589999000000001	0.1721990920566418
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.004589999000000001	0.1721990920566418
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.004589999000000001	0.1721990920566418
HYPOPHOSPHATASIA	0.004589999000000001	0.1721990920566418
NOONAN SYNDROME 7; NS7	0.004589999000000001	0.1721990920566418
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.004589999000000001	0.1721990920566418
PETERS-PLUS SYNDROME; PTRPLS	0.004589999000000001	0.1721990920566418
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.004589999000000001	0.1721990920566418
ARGININOSUCCINIC ACIDURIA	0.004589999000000001	0.1721990920566418
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.004589999000000001	0.1721990920566418
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.004589999000000001	0.1721990920566418
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.004589999000000001	0.1721990920566418
PEHO SYNDROME; PEHO	0.004589999000000001	0.1721990920566418
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.004589999000000001	0.1721990920566418
SHASHI-PENA SYNDROME; SHAPNS	0.004589999000000001	0.1721990920566418
KOOLEN-DE VRIES SYNDROME	0.004589999000000001	0.1721990920566418
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.004589999000000001	0.1721990920566418
MAPLE SYRUP URINE DISEASE; MSUD	0.004589999000000001	0.1721990920566418
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.004589999000000001	0.1721990920566418
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.004589999000000001	0.1721990920566418
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.004589999000000001	0.1721990920566418
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.004112849	0.15429826097262048
2Q23.1 MICRODELETION SYNDROME	0.004112849	0.15429826097262048
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.004112849	0.15429826097262048
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.004112849	0.15429826097262048
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.004112849	0.15429826097262048
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.004112849	0.15429826097262048
FAMILIAL MEDITERRANEAN FEVER	0.004112849	0.15429826097262048
LOWE OCULOCEREBRORENAL SYNDROME	0.004112849	0.15429826097262048
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.004112849	0.15429826097262048
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.004112849	0.15429826097262048
ALEXANDER DISEASE	0.004112849	0.15429826097262048
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.004112849	0.15429826097262048
KLEEFSTRA SYNDROME	0.004112849	0.15429826097262048
AUTISM, SUSCEPTIBILITY TO, 18	0.004112849	0.15429826097262048
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.004112849	0.15429826097262048
9Q33.3Q34.11 MICRODELETION SYNDROME	0.004112849	0.15429826097262048
RETT SYNDROME; RTT	0.004112849	0.15429826097262048
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.004112849	0.15429826097262048
TRISOMY 8P	0.004112849	0.15429826097262048
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.004112849	0.15429826097262048
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.004112849	0.15429826097262048
FAMILIAL COLORECTAL CANCER TYPE X	0.004112849	0.15429826097262048
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.004112849	0.15429826097262048
PORPHYRIA VARIEGATA	0.004112849	0.15429826097262048
MOWAT-WILSON SYNDROME	0.004112849	0.15429826097262048
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.004112849	0.15429826097262048
LYNCH SYNDROME	0.004112849	0.15429826097262048
TEMPLE-BARAITSER SYNDROME	0.004112849	0.15429826097262048
49,XXXXY SYNDROME	0.004112849	0.15429826097262048
48,XXXY SYNDROME	0.004112849	0.15429826097262048
RETT SYNDROME, CONGENITAL VARIANT	0.004112849	0.15429826097262048
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.004112849	0.15429826097262048
DDOST-CDG	0.004112849	0.15429826097262048
PITT-HOPKINS SYNDROME	0.004112849	0.15429826097262048
611961 STEVENSON-CAREY SYNDROME	0.004112849	0.15429826097262048
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.004112849	0.15429826097262048
HYPOPHOSPHATASIA, INFANTILE	0.004112849	0.15429826097262048
ADIPOSIS DOLOROSA	0.004112849	0.15429826097262048
ACUTE INTERMITTENT PORPHYRIA	0.004112849	0.15429826097262048
WIEDEMANN-STEINER SYNDROME; WDSTS	0.004112849	0.15429826097262048
HEREDITARY COPROPORPHYRIA	0.004112849	0.15429826097262048
PORPHYRIA	0.004112849	0.15429826097262048
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.004112849	0.15429826097262048
ACUTE ADRENAL INSUFFICIENCY	0.004112849	0.15429826097262048
HEREDITARY FRUCTOSE INTOLERANCE	0.004112849	0.15429826097262048
KAPUR-TORIELLO SYNDROME	0.004112849	0.15429826097262048
SMITH-MAGENIS SYNDROME; SMS	0.004112849	0.15429826097262048
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.004112849	0.15429826097262048
C SYNDROME	0.004112849	0.15429826097262048
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.004112849	0.15429826097262048
ADDISON DISEASE	0.004112849	0.15429826097262048
PAROXYSMAL EXTREME PAIN DISORDER	0.004112849	0.15429826097262048
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.004112849	0.15429826097262048
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.004112849	0.15429826097262048
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.004112849	0.15429826097262048
GITELMAN SYNDROME	0.004112849	0.15429826097262048
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.00404858	0.15188713551324928
DERMATOMYOSITIS	0.00404858	0.15188713551324928
CAFFEY DISEASE	0.00404858	0.15188713551324928
CAMURATI-ENGELMANN DISEASE	0.00404858	0.15188713551324928
OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.00404858	0.15188713551324928
RING CHROMOSOME 1 SYNDROME	0.00404858	0.15188713551324928
ESOPHAGEAL ATRESIA	0.00404858	0.15188713551324928
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.00404858	0.15188713551324928
FREEMAN-SHELDON SYNDROME	0.00404858	0.15188713551324928
CATARACT-INTELLECTUAL DISABILITY-HYPOGONADISM SYNDROME	0.00404858	0.15188713551324928
CHERUBISM	0.00404858	0.15188713551324928
AORTIC ARCH DEFECTS	0.00404858	0.15188713551324928
PRADER-WILLI SYNDROME (TYPE 1)	0.00404858	0.15188713551324928
SQUAMOUS CELL CARCINOMA OF THE ESOPHAGUS	0.00404858	0.15188713551324928
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.00404858	0.15188713551324928
ALLAN-HERNDON-DUDLEY SYNDROME	0.00404858	0.15188713551324928
3C SYNDROME	0.00404858	0.15188713551324928
PEMPHIGUS VULGARIS	0.00404858	0.15188713551324928
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.00404858	0.15188713551324928
PIERRE ROBIN SYNDROME	0.00404858	0.15188713551324928
STVE-WIEDEMANN SYNDROME	0.00404858	0.15188713551324928
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.00404858	0.15188713551324928
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.00404858	0.15188713551324928
METHYLMALONIC ACIDURIA, CBLB TYPE	0.00404858	0.15188713551324928
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00404858	0.15188713551324928
236450 HUTTERITE CEREBROOSTEONEPHRODYSPLASIA SYNDROME;;COND;;CEREBROOSTEONEPHOSIS SYNDROME	0.00404858	0.15188713551324928
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.00404858	0.15188713551324928
DUBOWITZ SYNDROME	0.00404858	0.15188713551324928
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.00404858	0.15188713551324928
MARTSOLF SYNDROME	0.00404858	0.15188713551324928
ISOLATED POLYCYSTIC LIVER DISEASE	0.00404858	0.15188713551324928
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.00404858	0.15188713551324928
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.00404858	0.15188713551324928
HYPERKALEMIC PERIODIC PARALYSIS	0.00404858	0.15188713551324928
JOUBERT SYNDROME 10	0.00404858	0.15188713551324928
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.00404858	0.15188713551324928
NOONAN SYNDROME	0.00404858	0.15188713551324928
NEMALINE MYOPATHY 4	0.00404858	0.15188713551324928
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.00404858	0.15188713551324928
HOMOZYGOUS 11P15-P14 DELETION SYNDROME	0.00404858	0.15188713551324928
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.00404858	0.15188713551324928
CONGENITAL ADRENAL HYPERPLASIA	0.00404858	0.15188713551324928
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.00404858	0.15188713551324928
JEUNE SYNDROME	0.00404858	0.15188713551324928
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.00404858	0.15188713551324928
HYPOGLOSSIA WITH SITUS INVERSUS	0.00404858	0.15188713551324928
GOLDENHAR SYNDROME	0.00404858	0.15188713551324928
AICARDI-GOUTIERES SYNDROME 5	0.00404858	0.15188713551324928
LIVER FAILURE, INFANTILE, TRANSIENT	0.00404858	0.15188713551324928
LEPRECHAUNISM	0.00404858	0.15188713551324928
WEAVER SYNDROME	0.00404858	0.15188713551324928
MOEBIUS SYNDROME	0.00404858	0.15188713551324928
INCLUSION BODY MYOSITIS	0.00404858	0.15188713551324928
POTASSIUM-AGGRAVATED MYOTONIA	0.00404858	0.15188713551324928
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.00404858	0.15188713551324928
%608572 BURN-MCKEOWN SYNDROME	0.00404858	0.15188713551324928
2P15-16.1 MICRODELETION SYNDROME	0.00404858	0.15188713551324928
MOEBIUS SYNDROME; MBS	0.00404858	0.15188713551324928
ADENOCARCINOMA OF THE ESOPHAGUS	0.00404858	0.15188713551324928
MYOTONIC DYSTROPHY 1	0.00404858	0.15188713551324928
NEMALINE MYOPATHY 3; NEM3	0.00404858	0.15188713551324928
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.00404858	0.15188713551324928
PRADER-WILLI SYNDROME (TYPE 2)	0.00404858	0.15188713551324928
17Q21.31 RECURRENT MICRODELETION SYNDROME	0.00404858	0.15188713551324928
OCULOFACIOCARDIODENTAL SYNDROME	0.00404858	0.15188713551324928
16P11.2-P12.2 MICRODELETION SYNDROME	0.00404858	0.15188713551324928
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.00404858	0.15188713551324928
CRI-DU-CHAT SYNDROME	0.00404858	0.15188713551324928
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.00404858	0.15188713551324928
HYPOGLOSSIA-HYPODACTYLY SYNDROME	0.00404858	0.15188713551324928
TYPHOID	0.00357143	0.133986304429228
MULTIPLE SYSTEM ATROPHY, CEREBELLAR TYPE	0.00357143	0.133986304429228
PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22	0.00357143	0.133986304429228
TURCOT SYNDROME WITH POLYPOSIS	0.00357143	0.133986304429228
PUDENDAL NEURALGIA	0.00357143	0.133986304429228
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.00357143	0.133986304429228
PRIMARY PARATHYROID HYPERPLASIA	0.00357143	0.133986304429228
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.00357143	0.133986304429228
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.00357143	0.133986304429228
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	0.00357143	0.133986304429228
MULTIPLE SYSTEM ATROPHY	0.00357143	0.133986304429228
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.00357143	0.133986304429228
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.00357143	0.133986304429228
MULTIPLE SYSTEM ATROPHY, PARKINSONIAN TYPE	0.00357143	0.133986304429228
PROPIONIC ACIDEMIA	0.00357143	0.133986304429228
PARATHYROID CARCINOMA	0.00357143	0.133986304429228
FG SYNDROME 2; FGS2	0.00357143	0.133986304429228
POLYMYOSITIS	0.00357143	0.133986304429228
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.00357143	0.133986304429228
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.00357143	0.133986304429228
HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; HSCR1	0.00357143	0.133986304429228
THYROTROPIN-RELEASING HORMONE DEFICIENCY	0.00357143	0.133986304429228
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.00357143	0.133986304429228
ANAL SPHINCTER MYOPATHY, INTERNAL	0.00357143	0.133986304429228
MALT LYMPHOMA	0.00357143	0.133986304429228
NEUROENDOCRINE TUMOR OF ANAL CANAL	0.00357143	0.133986304429228
NEUROENDOCRINE TUMOR OF THE RECTUM	0.00357143	0.133986304429228
PURE AUTONOMIC FAILURE	0.00357143	0.133986304429228
LAMBERT-EATON MYASTHENIC SYNDROME	0.00357143	0.133986304429228
SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA	0.00357143	0.133986304429228
GASTROINTESTINAL STROMAL TUMOR	0.00357143	0.133986304429228
13Q12.3 MICRODELETION SYNDROME	0.00357143	0.133986304429228
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.00357143	0.133986304429228
CAP POLYPOSIS	0.00357143	0.133986304429228
NEPHROPATHIC INFANTILE CYSTINOSIS	0.00357143	0.133986304429228
DIASTASIS RECTI AND WEAKNESS OF THE LINEA ALBA	0.00357143	0.133986304429228
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.00357143	0.133986304429228
MYOPATHY, MYOFIBRILLAR, 1; MFM1	0.00357143	0.133986304429228
HIRSCHSPRUNG DISEASE	0.00357143	0.133986304429228
HYPERPARATHYROIDISM-JAW TUMOR SYNDROME	0.00357143	0.133986304429228
IGG4-RELATED RETROPERITONEAL FIBROSIS	0.00357143	0.133986304429228
NEUROFERRITINOPATHY	0.00357143	0.133986304429228
SACRAL DEFECT WITH ANTERIOR MENINGOCELE	0.00357143	0.133986304429228
IATROGENIC BOTULISM	0.00357143	0.133986304429228
INHALATIONAL BOTULISM	0.00357143	0.133986304429228
ADIPOSIS DOLOROSA	0.00357143	0.133986304429228
THYROTOXIC PERIODIC PARALYSIS	0.00357143	0.133986304429228
LIDDLE SYNDROME	0.00357143	0.133986304429228
NEUROENDOCRINE NEOPLASM OF APPENDIX	0.00357143	0.133986304429228
MATERNALLY-INHERITED DIABETES AND DEAFNESS	0.00357143	0.133986304429228
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.00357143	0.133986304429228
FOODBORNE BOTULISM	0.00357143	0.133986304429228
INFANT BOTULISM	0.00357143	0.133986304429228
PSEUDOMYXOMA PERITONEI	0.00357143	0.133986304429228
SECONDARY SHORT BOWEL SYNDROME	0.00357143	0.133986304429228
PRIMARY PERITONEAL CARCINOMA	0.00357143	0.133986304429228
YOUNG-ONSET PARKINSON DISEASE	0.00357143	0.133986304429228
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.00357143	0.133986304429228
ATTRV30M AMYLOIDOSIS	0.00357143	0.133986304429228
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.00357143	0.133986304429228
FAMILIAL THYROID DYSHORMONOGENESIS	0.00357143	0.133986304429228
COFFIN-SIRIS SYNDROME 6; CSS6	0.00357143	0.133986304429228
TOWNES-BROCKS SYNDROME	0.00357143	0.133986304429228
UROFACIAL SYNDROME	0.00357143	0.133986304429228
PPOMA	0.00357143	0.133986304429228
GRFOMA	0.00357143	0.133986304429228
WAARDENBURG-SHAH SYNDROME	0.00357143	0.133986304429228
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.00357143	0.133986304429228
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.00357143	0.133986304429228
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.00357143	0.133986304429228
PRUNE BELLY SYNDROME	0.00357143	0.133986304429228
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.00357143	0.133986304429228
WILLIAMS SYNDROME	0.00357143	0.133986304429228
OCHOA SYNDROME	0.00357143	0.133986304429228
VISCERAL MYOPATHY; VSCM	0.00357143	0.133986304429228
THYROID ECTOPIA	0.00357143	0.133986304429228
JUVENILE DERMATOMYOSITIS	0.00357143	0.133986304429228
RHEUMATIC FEVER	0.00357143	0.133986304429228
HINMAN SYNDROME	0.00357143	0.133986304429228
KAPUR-TORIELLO SYNDROME	0.00357143	0.133986304429228
THYROID HYPOPLASIA	0.00357143	0.133986304429228
SEVERE GENERALIZED RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.00357143	0.133986304429228
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA INVERSA	0.00357143	0.133986304429228
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.00357143	0.133986304429228
SOMATOSTATINOMA	0.00357143	0.133986304429228
PERITONEAL CYSTIC MESOTHELIOMA	0.00357143	0.133986304429228
MYXEDEMA	0.00357143	0.133986304429228
NK-CELL ENTEROPATHY	0.00357143	0.133986304429228
UROFACIAL SYNDROME 2	0.00357143	0.133986304429228
BOTULISM	0.00357143	0.133986304429228
%193250 VOLVULUS OF MIDGUT;;INTESTINAL MALROTATION, FAMILIAL	0.00357143	0.133986304429228
THYROID HEMIAGENESIS	0.00357143	0.133986304429228
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7	0.00357143	0.133986304429228
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.00357143	0.133986304429228
TOXIN-MEDIATED INFECTIOUS BOTULISM	0.00357143	0.133986304429228
GLUCAGONOMA	0.00357143	0.133986304429228
WOUND BOTULISM	0.00357143	0.133986304429228
PORPHYRIA VARIEGATA	0.00357143	0.133986304429228
PARKINSON DISEASE, LATE-ONSET; PD	0.00357143	0.133986304429228
11Q22.2Q22.3 MICRODELETION SYNDROME	0.0027106189999999996	0.10169198963038599
PALLISTER-KILLIAN SYNDROME	0.0027106189999999996	0.10169198963038599
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.0027106189999999996	0.10169198963038599
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.0027106189999999996	0.10169198963038599
PHELAN-MCDERMID SYNDROME	0.0027106189999999996	0.10169198963038599
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.0027106189999999996	0.10169198963038599
PIERPONT SYNDROME	0.0027106189999999996	0.10169198963038599
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.0027106189999999996	0.10169198963038599
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.0027106189999999996	0.10169198963038599
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.0027106189999999996	0.10169198963038599
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.0027106189999999996	0.10169198963038599
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.0027106189999999996	0.10169198963038599
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.0027106189999999996	0.10169198963038599
MONOSOMY 22Q13.3	0.0027106189999999996	0.10169198963038599
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.0027106189999999996	0.10169198963038599
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.0027106189999999996	0.10169198963038599
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.0027106189999999996	0.10169198963038599
PMM2-CDG	0.0027106189999999996	0.10169198963038599
BOHRING-OPITZ SYNDROME	0.0027106189999999996	0.10169198963038599
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.0027106189999999996	0.10169198963038599
COCKAYNE SYNDROME	0.0027106189999999996	0.10169198963038599
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.0027106189999999996	0.10169198963038599
CRISPONI SYNDROME	0.0027106189999999996	0.10169198963038599
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.0027106189999999996	0.10169198963038599
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.0027106189999999996	0.10169198963038599
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.0027106189999999996	0.10169198963038599
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.0027106189999999996	0.10169198963038599
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.0027106189999999996	0.10169198963038599
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.0027106189999999996	0.10169198963038599
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.0027106189999999996	0.10169198963038599
17Q24.2 MICRODELETION SYNDROME	0.0027106189999999996	0.10169198963038599
GENITOPATELLAR SYNDROME	0.0027106189999999996	0.10169198963038599
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.0027106189999999996	0.10169198963038599
ACUTE BILIRUBIN ENCEPHALOPATHY	0.0027106189999999996	0.10169198963038599
MONOSOMY 9Q22.3	0.0027106189999999996	0.10169198963038599
GAUCHER DISEASE, TYPE II	0.0027106189999999996	0.10169198963038599
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.0027106189999999996	0.10169198963038599
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.0027106189999999996	0.10169198963038599
WIEACKER-WOLFF SYNDROME	0.0027106189999999996	0.10169198963038599
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.0027106189999999996	0.10169198963038599
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.0027106189999999996	0.10169198963038599
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.0027106189999999996	0.10169198963038599
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.0027106189999999996	0.10169198963038599
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.0027106189999999996	0.10169198963038599
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.0027106189999999996	0.10169198963038599
AICARDI-GOUTIERES SYNDROME 7	0.0027106189999999996	0.10169198963038599
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.0027106189999999996	0.10169198963038599
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.0027106189999999996	0.10169198963038599
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.0027106189999999996	0.10169198963038599
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.0027106189999999996	0.10169198963038599
CHOREOACANTHOCYTOSIS	0.0027106189999999996	0.10169198963038599
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.0027106189999999996	0.10169198963038599
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.0027106189999999996	0.10169198963038599
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.0027106189999999996	0.10169198963038599
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.0027106189999999996	0.10169198963038599
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.0027106189999999996	0.10169198963038599
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.0027106189999999996	0.10169198963038599
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.0027106189999999996	0.10169198963038599
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.0027106189999999996	0.10169198963038599
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.0027106189999999996	0.10169198963038599
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.0027106189999999996	0.10169198963038599
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.0027106189999999996	0.10169198963038599
KABUKI SYNDROME	0.0027106189999999996	0.10169198963038599
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.0027106189999999996	0.10169198963038599
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.0027106189999999996	0.10169198963038599
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.0027106189999999996	0.10169198963038599
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.0027106189999999996	0.10169198963038599
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.0027106189999999996	0.10169198963038599
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.0027106189999999996	0.10169198963038599
KBG SYNDROME	0.0027106189999999996	0.10169198963038599
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.0027106189999999996	0.10169198963038599
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.0027106189999999996	0.10169198963038599
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.0027106189999999996	0.10169198963038599
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.0027106189999999996	0.10169198963038599
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.0027106189999999996	0.10169198963038599
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.0027106189999999996	0.10169198963038599
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.0027106189999999996	0.10169198963038599
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.0027106189999999996	0.10169198963038599
RFT1-CDG	0.0027106189999999996	0.10169198963038599
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.0027106189999999996	0.10169198963038599
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.0027106189999999996	0.10169198963038599
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.0027106189999999996	0.10169198963038599
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.0027106189999999996	0.10169198963038599
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.0027106189999999996	0.10169198963038599
17Q12 MICRODELETION SYNDROME	0.0027106189999999996	0.10169198963038599
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.0027106189999999996	0.10169198963038599
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.0027106189999999996	0.10169198963038599
14Q12 MICRODELETION SYNDROME	0.0027106189999999996	0.10169198963038599
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.0027106189999999996	0.10169198963038599
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.0027106189999999996	0.10169198963038599
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.0027106189999999996	0.10169198963038599
ZTTK SYNDROME; ZTTKS	0.0027106189999999996	0.10169198963038599
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.0027106189999999996	0.10169198963038599
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.0027106189999999996	0.10169198963038599
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.0027106189999999996	0.10169198963038599
COFFIN-SIRIS SYNDROME 5	0.0027106189999999996	0.10169198963038599
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.0027106189999999996	0.10169198963038599
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.0027106189999999996	0.10169198963038599
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.0027106189999999996	0.10169198963038599
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.0027106189999999996	0.10169198963038599
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.0027106189999999996	0.10169198963038599
ALG11-CDG	0.0027106189999999996	0.10169198963038599
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.0027106189999999996	0.10169198963038599
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.0027106189999999996	0.10169198963038599
SMITH-KINGSMORE SYNDROME; SKS	0.0027106189999999996	0.10169198963038599
CITRULLINEMIA TYPE I	0.0027106189999999996	0.10169198963038599
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.0027106189999999996	0.10169198963038599
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.0027106189999999996	0.10169198963038599
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.0027106189999999996	0.10169198963038599
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.0027106189999999996	0.10169198963038599
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.0027106189999999996	0.10169198963038599
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.0027106189999999996	0.10169198963038599
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.0027106189999999996	0.10169198963038599
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.0027106189999999996	0.10169198963038599
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.0027106189999999996	0.10169198963038599
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.0027106189999999996	0.10169198963038599
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.0027106189999999996	0.10169198963038599
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.0027106189999999996	0.10169198963038599
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.0027106189999999996	0.10169198963038599
RETINITIS PIGMENTOSA 59; RP59	0.0027106189999999996	0.10169198963038599
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.0027106189999999996	0.10169198963038599
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.0027106189999999996	0.10169198963038599
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.0027106189999999996	0.10169198963038599
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.0027106189999999996	0.10169198963038599
STT3A-CDG	0.0027106189999999996	0.10169198963038599
STT3B-CDG	0.0027106189999999996	0.10169198963038599
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.0027106189999999996	0.10169198963038599
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.0027106189999999996	0.10169198963038599
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.0027106189999999996	0.10169198963038599
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.0027106189999999996	0.10169198963038599
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.0027106189999999996	0.10169198963038599
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.0027106189999999996	0.10169198963038599
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.0027106189999999996	0.10169198963038599
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.0027106189999999996	0.10169198963038599
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.0027106189999999996	0.10169198963038599
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.0027106189999999996	0.10169198963038599
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.0027106189999999996	0.10169198963038599
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.0027106189999999996	0.10169198963038599
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.0027106189999999996	0.10169198963038599
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.0027106189999999996	0.10169198963038599
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.0027106189999999996	0.10169198963038599
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.0027106189999999996	0.10169198963038599
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.0027106189999999996	0.10169198963038599
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.0027106189999999996	0.10169198963038599
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.0027106189999999996	0.10169198963038599
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.0027106189999999996	0.10169198963038599
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.0027106189999999996	0.10169198963038599
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.0027106189999999996	0.10169198963038599
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.0027106189999999996	0.10169198963038599
TETRASOMY 9P	0.0027106189999999996	0.10169198963038599
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.0027106189999999996	0.10169198963038599
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.0027106189999999996	0.10169198963038599
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.0027106189999999996	0.10169198963038599
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.0027106189999999996	0.10169198963038599
COFFIN-SIRIS SYNDROME 4; CSS4	0.0027106189999999996	0.10169198963038599
COFFIN-SIRIS SYNDROME 3; CSS3	0.0027106189999999996	0.10169198963038599
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.0027106189999999996	0.10169198963038599
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.0027106189999999996	0.10169198963038599
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.0027106189999999996	0.10169198963038599
COFFIN-SIRIS SYNDROME 2; CSS2	0.0027106189999999996	0.10169198963038599
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.0027106189999999996	0.10169198963038599
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.0027106189999999996	0.10169198963038599
DUPLICATION/INVERSION 15Q11	0.0027106189999999996	0.10169198963038599
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.0027106189999999996	0.10169198963038599
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.0027106189999999996	0.10169198963038599
PONTINE TEGMENTAL CAP DYSPLASIA	0.0027106189999999996	0.10169198963038599
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.0021691999999999996	0.08138003308699353
JUNCTIONAL EPIDERMOLYSIS BULLOSA, GENERALIZED SEVERE	0.0021691999999999996	0.08138003308699353
SANDIFER SYNDROME	0.0021691999999999996	0.08138003308699353
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.0021691999999999996	0.08138003308699353
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.0021691999999999996	0.08138003308699353
2Q32Q33 MICRODELETION SYNDROME	0.0021691999999999996	0.08138003308699353
48,XYYY SYNDROME	0.0021691999999999996	0.08138003308699353
19Q13.11 MICRODELETION SYNDROME	0.0021691999999999996	0.08138003308699353
PRIMARY CONGENITAL HYPOTHYROIDISM	0.0021691999999999996	0.08138003308699353
PRIMARY DYSTONIA, DYT2 TYPE	0.0021691999999999996	0.08138003308699353
16P11.2P12.2 MICRODELETION SYNDROME	0.0021691999999999996	0.08138003308699353
APHONIA-DEAFNESS-RETINAL DYSTROPHY-BIFID HALLUCES-INTELLECTUAL DISABILITY SYNDROME	0.0021691999999999996	0.08138003308699353
CONGENITAL MYOPATHY WITH MYASTHENIC-LIKE ONSET	0.0021691999999999996	0.08138003308699353
ADENOCARCINOMA OF OVARY	0.0021691999999999996	0.08138003308699353
ISOLATED COMPLEX I DEFICIENCY	0.0021691999999999996	0.08138003308699353
X-LINKED MYOTUBULAR MYOPATHY-ABNORMAL GENITALIA SYNDROME	0.0021691999999999996	0.08138003308699353
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.0021691999999999996	0.08138003308699353
CLASSIC GALACTOSEMIA	0.0021691999999999996	0.08138003308699353
FAMILIAL HYPOALDOSTERONISM	0.0021691999999999996	0.08138003308699353
GALACTOSE EPIMERASE DEFICIENCY	0.0021691999999999996	0.08138003308699353
EAR-PATELLA-SHORT STATURE SYNDROME	0.0021691999999999996	0.08138003308699353
INFANTILE SYSTEMIC HYALINOSIS	0.0021691999999999996	0.08138003308699353
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.0021691999999999996	0.08138003308699353
PARAMYOTONIA CONGENITA OF VON EULENBURG	0.0021691999999999996	0.08138003308699353
ISOTRETINOIN-LIKE SYNDROME	0.0021691999999999996	0.08138003308699353
DOUBLE OUTLET RIGHT VENTRICLE	0.0021691999999999996	0.08138003308699353
CONGENITAL ADRENAL HYPERPLASIA DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY	0.0021691999999999996	0.08138003308699353
ADULT-ONSET NEMALINE MYOPATHY	0.0021691999999999996	0.08138003308699353
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.0021691999999999996	0.08138003308699353
EARLY-ONSET FAMILIAL HYPOALDOSTERONISM	0.0021691999999999996	0.08138003308699353
TYPICAL NEMALINE MYOPATHY	0.0021691999999999996	0.08138003308699353
LOCKED-IN SYNDROME	0.0021691999999999996	0.08138003308699353
HURLER SYNDROME	0.0021691999999999996	0.08138003308699353
SPINOCEREBELLAR ATAXIA TYPE 7	0.0021691999999999996	0.08138003308699353
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.0021691999999999996	0.08138003308699353
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.0021691999999999996	0.08138003308699353
NEONATAL MARFAN SYNDROME	0.0021691999999999996	0.08138003308699353
CHILDHOOD APRAXIA OF SPEECH	0.0021691999999999996	0.08138003308699353
CLEFT LIP WITH OR WITHOUT CLEFT PALATE	0.0021691999999999996	0.08138003308699353
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.0021691999999999996	0.08138003308699353
NATIVE AMERICAN MYOPATHY	0.0021691999999999996	0.08138003308699353
TRIGEMINAL NEURALGIA	0.0021691999999999996	0.08138003308699353
LYSOSOMAL ACID LIPASE DEFICIENCY	0.0021691999999999996	0.08138003308699353
OROFACIODIGITAL SYNDROME TYPE 4	0.0021691999999999996	0.08138003308699353
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.0021691999999999996	0.08138003308699353
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.0021691999999999996	0.08138003308699353
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.0021691999999999996	0.08138003308699353
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.0021691999999999996	0.08138003308699353
VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.0021691999999999996	0.08138003308699353
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.0021691999999999996	0.08138003308699353
BAKER-GORDON SYNDROME; BAGOS	0.0021691999999999996	0.08138003308699353
MITOCHONDRIAL DNA DEPLETION SYNDROME 16 (HEPATIC TYPE); MTDPS16	0.0021691999999999996	0.08138003308699353
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.0021691999999999996	0.08138003308699353
CHIARI MALFORMATION TYPE II	0.0021691999999999996	0.08138003308699353
MYASTHENIC SYNDROME, CONGENITAL, 4B, FAST-CHANNEL; CMS4B	0.0021691999999999996	0.08138003308699353
MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11	0.0021691999999999996	0.08138003308699353
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.0021691999999999996	0.08138003308699353
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.0021691999999999996	0.08138003308699353
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.0021691999999999996	0.08138003308699353
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.0021691999999999996	0.08138003308699353
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.0021691999999999996	0.08138003308699353
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.0021691999999999996	0.08138003308699353
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.0021691999999999996	0.08138003308699353
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.0021691999999999996	0.08138003308699353
MEIER-GORLIN SYNDROME 3; MGORS3	0.0021691999999999996	0.08138003308699353
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.0021691999999999996	0.08138003308699353
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.0021691999999999996	0.08138003308699353
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.0021691999999999996	0.08138003308699353
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.0021691999999999996	0.08138003308699353
STUVE-WIEDEMANN SYNDROME	0.0021691999999999996	0.08138003308699353
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.0021691999999999996	0.08138003308699353
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.0021691999999999996	0.08138003308699353
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.0021691999999999996	0.08138003308699353
VAN MALDERGEM SYNDROME 1; VMLDS1	0.0021691999999999996	0.08138003308699353
MEIER-GORLIN SYNDROME 5; MGORS5	0.0021691999999999996	0.08138003308699353
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.0021691999999999996	0.08138003308699353
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.0021691999999999996	0.08138003308699353
MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C	0.0021691999999999996	0.08138003308699353
MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL; CMS3B	0.0021691999999999996	0.08138003308699353
GABRIELE-DE VRIES SYNDROME; GADEVS	0.0021691999999999996	0.08138003308699353
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.0021691999999999996	0.08138003308699353
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.0021691999999999996	0.08138003308699353
LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY	0.0021691999999999996	0.08138003308699353
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.0021691999999999996	0.08138003308699353
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.0021691999999999996	0.08138003308699353
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.0021691999999999996	0.08138003308699353
POPOV-CHANG SYNDROME; POPCHAS	0.0021691999999999996	0.08138003308699353
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.0021691999999999996	0.08138003308699353
NEMALINE MYOPATHY 2; NEM2	0.0021691999999999996	0.08138003308699353
TONNE-KALSCHEUER SYNDROME; TOKAS	0.0021691999999999996	0.08138003308699353
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.0021691999999999996	0.08138003308699353
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.0021691999999999996	0.08138003308699353
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.0021691999999999996	0.08138003308699353
PEROXISOME BIOGENESIS DISORDER 11B	0.0021691999999999996	0.08138003308699353
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.0021691999999999996	0.08138003308699353
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.0021691999999999996	0.08138003308699353
VAN MALDERGEM SYNDROME 2; VMLDS2	0.0021691999999999996	0.08138003308699353
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.0021691999999999996	0.08138003308699353
MYASTHENIC SYNDROME, CONGENITAL, 17; CMS17	0.0021691999999999996	0.08138003308699353
MYASTHENIC SYNDROME, CONGENITAL, 2C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS2C	0.0021691999999999996	0.08138003308699353
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.0021691999999999996	0.08138003308699353
ATRESIA OF SMALL INTESTINE	0.0021691999999999996	0.08138003308699353
MEIER-GORLIN SYNDROME 2; MGORS2	0.0021691999999999996	0.08138003308699353
MUSCULAR DYSTROPHY, CONGENITAL, DAVIGNON-CHAUVEAU TYPE; MDCDC	0.0021691999999999996	0.08138003308699353
HYPERPARATHYROIDISM, TRANSIENT NEONATAL; HRPTTN	0.0021691999999999996	0.08138003308699353
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.0021691999999999996	0.08138003308699353
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.0021691999999999996	0.08138003308699353
CRISPONI/COLD-INDUCED SWEATING SYNDROME 3; CISS3	0.0021691999999999996	0.08138003308699353
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.0021691999999999996	0.08138003308699353
CHROMOSOME 17P13.1 DELETION SYNDROME	0.0021691999999999996	0.08138003308699353
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.0021691999999999996	0.08138003308699353
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.0021691999999999996	0.08138003308699353
CRISS-CROSS HEART	0.0021691999999999996	0.08138003308699353
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.0021691999999999996	0.08138003308699353
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.0021691999999999996	0.08138003308699353
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.0021691999999999996	0.08138003308699353
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.0021691999999999996	0.08138003308699353
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.0021691999999999996	0.08138003308699353
FONTAINE PROGEROID SYNDROME; FPS	0.0021691999999999996	0.08138003308699353
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.0021691999999999996	0.08138003308699353
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.0021691999999999996	0.08138003308699353
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.0021691999999999996	0.08138003308699353
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.0021691999999999996	0.08138003308699353
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.0021691999999999996	0.08138003308699353
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.0021691999999999996	0.08138003308699353
AURICULOCONDYLAR SYNDROME	0.0021691999999999996	0.08138003308699353
CHOANAL ATRESIA	0.0021691999999999996	0.08138003308699353
CEREBROCOSTOMANDIBULAR SYNDROME	0.0021691999999999996	0.08138003308699353
LARYNGOTRACHEAL ANGIOMA	0.0021691999999999996	0.08138003308699353
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.000541419	0.020311956543392476
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.000541419	0.020311956543392476
RENPENNING SYNDROME 1; RENS1	0.000541419	0.020311956543392476
MUCOPOLYSACCHARIDOSIS, TYPE II	0.000541419	0.020311956543392476
WYBURN-MASON SYNDROME	0.000541419	0.020311956543392476
OROFACIODIGITAL SYNDROME I; OFD1	0.000541419	0.020311956543392476
LYMPHANGIOLEIOMYOMATOSIS	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 9	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.000541419	0.020311956543392476
ETHYLMALONIC ENCEPHALOPATHY	0.000541419	0.020311956543392476
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 1	0.000541419	0.020311956543392476
LEIGH SYNDROME	0.000541419	0.020311956543392476
WHIM SYNDROME	0.000541419	0.020311956543392476
XQ25 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392476
311450 PALLISTER W SYNDROME;;W SYNDROME	0.000541419	0.020311956543392476
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.000541419	0.020311956543392476
WAISMAN SYNDROME; WSMN	0.000541419	0.020311956543392476
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.000541419	0.020311956543392476
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.000541419	0.020311956543392476
PELIZAEUS-MERZBACHER DISEASE	0.000541419	0.020311956543392476
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.000541419	0.020311956543392476
MICROPHTHALMIA, SYNDROMIC 1	0.000541419	0.020311956543392476
COFFIN-LOWRY SYNDROME; CLS	0.000541419	0.020311956543392476
HHHH SYNDROME	0.000541419	0.020311956543392476
GLYCEROL KINASE DEFICIENCY; GKD	0.000541419	0.020311956543392476
HYPOPARATHYROIDISM, X-LINKED	0.000541419	0.020311956543392476
PETTIGREW SYNDROME	0.000541419	0.020311956543392476
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.000541419	0.020311956543392476
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.000541419	0.020311956543392476
LIPOID PROTEINOSIS	0.000541419	0.020311956543392476
MILLER-DIEKER SYNDROME	0.000541419	0.020311956543392476
METACHROMATIC LEUKODYSTROPHY	0.000541419	0.020311956543392476
INCONTINENTIA PIGMENTI; IP	0.000541419	0.020311956543392476
MAPLE SYRUP URINE DISEASE	0.000541419	0.020311956543392476
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.000541419	0.020311956543392476
MENKES DISEASE	0.000541419	0.020311956543392476
9Q21.13 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.000541419	0.020311956543392476
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.000541419	0.020311956543392476
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.000541419	0.020311956543392476
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.000541419	0.020311956543392476
AICARDI-GOUTIRES SYNDROME	0.000541419	0.020311956543392476
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000541419	0.020311956543392476
SHUKLA-VERNON SYNDROME; SHUVER	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000541419	0.020311956543392476
DILATED CARDIOMYOPATHY WITH ATAXIA	0.000541419	0.020311956543392476
CEDNIK SYNDROME	0.000541419	0.020311956543392476
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.000541419	0.020311956543392476
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.000541419	0.020311956543392476
FRAGILE X MENTAL RETARDATION SYNDROME	0.000541419	0.020311956543392476
ONDINE SYNDROME	0.000541419	0.020311956543392476
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.000541419	0.020311956543392476
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000541419	0.020311956543392476
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.000541419	0.020311956543392476
LHERMITTE-DUCLOS DISEASE	0.000541419	0.020311956543392476
LEBER CONGENITAL AMAUROSIS	0.000541419	0.020311956543392476
NORRIE DISEASE	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 90	0.000541419	0.020311956543392476
CLARK-BARAITSER SYNDROME	0.000541419	0.020311956543392476
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.000541419	0.020311956543392476
RECURRENT ACUTE PANCREATITIS	0.000541419	0.020311956543392476
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.000541419	0.020311956543392476
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.000541419	0.020311956543392476
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.000541419	0.020311956543392476
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.000541419	0.020311956543392476
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.000541419	0.020311956543392476
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.000541419	0.020311956543392476
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.000541419	0.020311956543392476
PRIMARY CUTIS VERTICIS GYRATA	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 82	0.000541419	0.020311956543392476
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 91; MRX91	0.000541419	0.020311956543392476
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.000541419	0.020311956543392476
NEVUS COMEDONICUS SYNDROME	0.000541419	0.020311956543392476
NIEMANN-PICK DISEASE TYPE C	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.000541419	0.020311956543392476
MUCOPOLYSACCHARIDOSIS TYPE 2	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 102	0.000541419	0.020311956543392476
CONGENITAL MYASTHENIC SYNDROME	0.000541419	0.020311956543392476
MYASTHENIA GRAVIS	0.000541419	0.020311956543392476
MUSCLE-EYE-BRAIN DISEASE	0.000541419	0.020311956543392476
MULTIPLE SULFATASE DEFICIENCY	0.000541419	0.020311956543392476
MUCOPOLYSACCHARIDOSIS TYPE 3	0.000541419	0.020311956543392476
MEND SYNDROME; MEND	0.000541419	0.020311956543392476
CENTRONUCLEAR MYOPATHY	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.000541419	0.020311956543392476
IMMUNODEFICIENCY 47	0.000541419	0.020311956543392476
MICROPHTHALMIA, LENZ TYPE	0.000541419	0.020311956543392476
XQ25 DUPLICATION SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 103	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 104; MRX104	0.000541419	0.020311956543392476
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.000541419	0.020311956543392476
X-LINKED CENTRONUCLEAR MYOPATHY	0.000541419	0.020311956543392476
NARP SYNDROME	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 88	0.000541419	0.020311956543392476
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.000541419	0.020311956543392476
ALSTRM SYNDROME	0.000541419	0.020311956543392476
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.000541419	0.020311956543392476
NEUROFIBROMATOSIS TYPE 1	0.000541419	0.020311956543392476
NETHERTON SYNDROME	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 101; MRX101	0.000541419	0.020311956543392476
LARGE CONGENITAL MELANOCYTIC NEVUS	0.000541419	0.020311956543392476
FAMILIAL MULTIPLE NEVI FLAMMEI	0.000541419	0.020311956543392476
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.000541419	0.020311956543392476
HEREDITARY METHEMOGLOBINEMIA	0.000541419	0.020311956543392476
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 100	0.000541419	0.020311956543392476
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.000541419	0.020311956543392476
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.000541419	0.020311956543392476
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.000541419	0.020311956543392476
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.000541419	0.020311956543392476
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.020311956543392476
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.000541419	0.020311956543392476
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.000541419	0.020311956543392476
SCHINDLER DISEASE, TYPE I	0.000541419	0.020311956543392476
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.000541419	0.020311956543392476
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.000541419	0.020311956543392476
KEPPEN-LUBINSKY SYNDROME	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.000541419	0.020311956543392476
CHROMOSOME 10Q26 DELETION SYNDROME	0.000541419	0.020311956543392476
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000541419	0.020311956543392476
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.000541419	0.020311956543392476
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.000541419	0.020311956543392476
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.000541419	0.020311956543392476
GLUTAMINE DEFICIENCY, CONGENITAL	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000541419	0.020311956543392476
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.000541419	0.020311956543392476
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.000541419	0.020311956543392476
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.000541419	0.020311956543392476
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.000541419	0.020311956543392476
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.000541419	0.020311956543392476
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.000541419	0.020311956543392476
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.000541419	0.020311956543392476
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.000541419	0.020311956543392476
PGM3-CDG	0.000541419	0.020311956543392476
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.000541419	0.020311956543392476
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.000541419	0.020311956543392476
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.000541419	0.020311956543392476
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.000541419	0.020311956543392476
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392476
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.000541419	0.020311956543392476
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.000541419	0.020311956543392476
NEONATAL ADRENOLEUKODYSTROPHY	0.000541419	0.020311956543392476
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.000541419	0.020311956543392476
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.000541419	0.020311956543392476
CONO-SPONDYLAR DYSPLASIA	0.000541419	0.020311956543392476
KLEEFSTRA SYNDROME	0.000541419	0.020311956543392476
PACHYGYRIA, FRONTOTEMPORAL	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.000541419	0.020311956543392476
LISSENCEPHALY 3; LIS3	0.000541419	0.020311956543392476
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.000541419	0.020311956543392476
TEMPLE-BARAITSER SYNDROME; TMBTS	0.000541419	0.020311956543392476
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.020311956543392476
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000541419	0.020311956543392476
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.000541419	0.020311956543392476
MEND SYNDROME	0.000541419	0.020311956543392476
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.000541419	0.020311956543392476
GLASS SYNDROME	0.000541419	0.020311956543392476
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392476
MAN1B1-CDG	0.000541419	0.020311956543392476
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.000541419	0.020311956543392476
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.000541419	0.020311956543392476
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.000541419	0.020311956543392476
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.000541419	0.020311956543392476
HYPERPROLINEMIA TYPE 1	0.000541419	0.020311956543392476
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.000541419	0.020311956543392476
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.000541419	0.020311956543392476
GYRATE ATROPHY OF CHOROID AND RETINA	0.000541419	0.020311956543392476
DYSTONIA-APHONIA SYNDROME	0.000541419	0.020311956543392476
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.000541419	0.020311956543392476
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000541419	0.020311956543392476
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.000541419	0.020311956543392476
ISOLATED GLYCEROL KINASE DEFICIENCY	0.000541419	0.020311956543392476
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.000541419	0.020311956543392476
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.000541419	0.020311956543392476
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.000541419	0.020311956543392476
CYCLIC VOMITING SYNDROME	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.000541419	0.020311956543392476
POTOCKI-SHAFFER SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.000541419	0.020311956543392476
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.000541419	0.020311956543392476
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.000541419	0.020311956543392476
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000541419	0.020311956543392476
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.000541419	0.020311956543392476
ALZHEIMER DISEASE 3; AD	0.000541419	0.020311956543392476
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000541419	0.020311956543392476
GRACILE BONE DYSPLASIA; GCLEB	0.000541419	0.020311956543392476
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.000541419	0.020311956543392476
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.000541419	0.020311956543392476
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000541419	0.020311956543392476
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.000541419	0.020311956543392476
MUENKE SYNDROME	0.000541419	0.020311956543392476
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000541419	0.020311956543392476
GURRIERI SYNDROME	0.000541419	0.020311956543392476
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.000541419	0.020311956543392476
AYME-GRIPP SYNDROME; AYGRP	0.000541419	0.020311956543392476
KEARNS-SAYRE SYNDROME; KSS	0.000541419	0.020311956543392476
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.000541419	0.020311956543392476
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.000541419	0.020311956543392476
OCULOECTODERMAL SYNDROME; OES	0.000541419	0.020311956543392476
BAND HETEROTOPIA; BH	0.000541419	0.020311956543392476
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000541419	0.020311956543392476
CODAS SYNDROME	0.000541419	0.020311956543392476
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.000541419	0.020311956543392476
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.000541419	0.020311956543392476
CHROMOSOME 2Q37 DELETION SYNDROME	0.000541419	0.020311956543392476
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000541419	0.020311956543392476
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.000541419	0.020311956543392476
TIMOTHY SYNDROME; TS	0.000541419	0.020311956543392476
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.000541419	0.020311956543392476
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000541419	0.020311956543392476
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392476
LATHOSTEROLOSIS	0.000541419	0.020311956543392476
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.000541419	0.020311956543392476
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392476
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.000541419	0.020311956543392476
LATHOSTEROLOSIS	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.000541419	0.020311956543392476
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.000541419	0.020311956543392476
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.000541419	0.020311956543392476
LISSENCEPHALY 1; LIS1	0.000541419	0.020311956543392476
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.000541419	0.020311956543392476
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.000541419	0.020311956543392476
GRISCELLI SYNDROME, TYPE 2; GS2	0.000541419	0.020311956543392476
NIEMANN-PICK DISEASE, TYPE C2	0.000541419	0.020311956543392476
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.000541419	0.020311956543392476
ADENYLOSUCCINATE LYASE DEFICIENCY	0.000541419	0.020311956543392476
KUFOR-RAKEB SYNDROME	0.000541419	0.020311956543392476
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.000541419	0.020311956543392476
INCONTINENTIA PIGMENTI	0.000541419	0.020311956543392476
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.000541419	0.020311956543392476
SLC39A8-CDG	0.000541419	0.020311956543392476
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.000541419	0.020311956543392476
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.000541419	0.020311956543392476
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.000541419	0.020311956543392476
SALLA DISEASE	0.000541419	0.020311956543392476
CRANIOSYNOSTOSIS 2	0.000541419	0.020311956543392476
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000541419	0.020311956543392476
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.000541419	0.020311956543392476
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.000541419	0.020311956543392476
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392476
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000541419	0.020311956543392476
ACQUIRED METHEMOGLOBINEMIA	0.000541419	0.020311956543392476
GLYCINE ENCEPHALOPATHY; GCE	0.000541419	0.020311956543392476
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.000541419	0.020311956543392476
ATKIN-FLAITZ SYNDROME	0.000541419	0.020311956543392476
RABIES	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000541419	0.020311956543392476
GRISCELLI SYNDROME, TYPE 1	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.000541419	0.020311956543392476
CEREBELLOPARENCHYMAL DISORDER II	0.000541419	0.020311956543392476
3-HYDROXYISOBUTYRIC ACIDURIA	0.000541419	0.020311956543392476
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.000541419	0.020311956543392476
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.000541419	0.020311956543392476
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.000541419	0.020311956543392476
THANATOPHORIC DYSPLASIA TYPE 2	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.000541419	0.020311956543392476
PFEIFFER SYNDROME TYPE 3	0.000541419	0.020311956543392476
PFEIFFER SYNDROME TYPE 2	0.000541419	0.020311956543392476
ASPARTYLGLUCOSAMINURIA	0.000541419	0.020311956543392476
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.000541419	0.020311956543392476
CITRULLINEMIA, CLASSIC	0.000541419	0.020311956543392476
COACH SYNDROME	0.000541419	0.020311956543392476
COCKAYNE SYNDROME A; CSA	0.000541419	0.020311956543392476
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.000541419	0.020311956543392476
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000541419	0.020311956543392476
SMITH-FINEMAN-MYERS SYNDROME	0.000541419	0.020311956543392476
RENIER-GABREELS-JASPER SYNDROME	0.000541419	0.020311956543392476
AUTISM	0.000541419	0.020311956543392476
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.000541419	0.020311956543392476
SECKEL SYNDROME 1; SCKL1	0.000541419	0.020311956543392476
COG8-CDG	0.000541419	0.020311956543392476
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.000541419	0.020311956543392476
BANGSTAD SYNDROME	0.000541419	0.020311956543392476
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000541419	0.020311956543392476
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.000541419	0.020311956543392476
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.000541419	0.020311956543392476
C SYNDROME	0.000541419	0.020311956543392476
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.000541419	0.020311956543392476
PARTINGTON SYNDROME	0.000541419	0.020311956543392476
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.000541419	0.020311956543392476
15Q24 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.000541419	0.020311956543392476
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000541419	0.020311956543392476
TEMTAMY SYNDROME; TEMTYS	0.000541419	0.020311956543392476
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.000541419	0.020311956543392476
EPILEPSY-TELANGIECTASIA	0.000541419	0.020311956543392476
FOUNTAIN SYNDROME	0.000541419	0.020311956543392476
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000541419	0.020311956543392476
HEREDITARY FOLATE MALABSORPTION	0.000541419	0.020311956543392476
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.000541419	0.020311956543392476
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.020311956543392476
ARGININEMIA	0.000541419	0.020311956543392476
FRYNS SYNDROME; FRNS	0.000541419	0.020311956543392476
GAPO SYNDROME; GAPOS	0.000541419	0.020311956543392476
GAUCHER DISEASE, TYPE IIIC	0.000541419	0.020311956543392476
BERNARD-SOULIER SYNDROME	0.000541419	0.020311956543392476
GLUTARIC ACIDEMIA I; GA1	0.000541419	0.020311956543392476
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.000541419	0.020311956543392476
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.000541419	0.020311956543392476
HARTNUP DISORDER	0.000541419	0.020311956543392476
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.000541419	0.020311956543392476
VISCERAL STEATOSIS, CONGENITAL	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.000541419	0.020311956543392476
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000541419	0.020311956543392476
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.000541419	0.020311956543392476
CROME SYNDROME	0.000541419	0.020311956543392476
XERODERMA PIGMENTOSUM	0.000541419	0.020311956543392476
CEREBROTENDINOUS XANTHOMATOSIS	0.000541419	0.020311956543392476
FRAGILE X SYNDROME	0.000541419	0.020311956543392476
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.000541419	0.020311956543392476
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.000541419	0.020311956543392476
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.000541419	0.020311956543392476
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.000541419	0.020311956543392476
DIAMINOPENTANURIA	0.000541419	0.020311956543392476
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.000541419	0.020311956543392476
224250 DYSMYELINATION WITH JAUNDICE	0.000541419	0.020311956543392476
DYSOSTEOSCLEROSIS	0.000541419	0.020311956543392476
JERVELL AND LANGE-NIELSEN SYNDROME	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.000541419	0.020311956543392476
ASPARTYLGLUCOSAMINURIA; AGU	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392476
SIALIDOSIS TYPE 2	0.000541419	0.020311956543392476
EPILEPSY, BENIGN OCCIPITAL	0.000541419	0.020311956543392476
CORNELIA DE LANGE SYNDROME 1	0.000541419	0.020311956543392476
DERMOTRICHIC SYNDROME	0.000541419	0.020311956543392476
CROUZON SYNDROME	0.000541419	0.020311956543392476
DARIER-WHITE DISEASE; DAR	0.000541419	0.020311956543392476
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.000541419	0.020311956543392476
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.000541419	0.020311956543392476
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.000541419	0.020311956543392476
EPILEPSY, READING	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.000541419	0.020311956543392476
ZIMMERMANN-LABAND SYNDROME 1	0.000541419	0.020311956543392476
FLYNN-AIRD SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, FRA12A TYPE	0.000541419	0.020311956543392476
MYHRE SYNDROME	0.000541419	0.020311956543392476
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.000541419	0.020311956543392476
SPINOCEREBELLAR ATAXIA TYPE 13	0.000541419	0.020311956543392476
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.000541419	0.020311956543392476
COPPER DEFICIENCY, FAMILIAL BENIGN	0.000541419	0.020311956543392476
HADDAD SYNDROME	0.000541419	0.020311956543392476
PAPILLORENAL SYNDROME	0.000541419	0.020311956543392476
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000541419	0.020311956543392476
1P36 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
ATYPICAL TERATOID RHABDOID TUMOR	0.000541419	0.020311956543392476
POTOCKI-SHAFFER SYNDROME	0.000541419	0.020311956543392476
ANGELMAN SYNDROME (TYPE 1)	0.000541419	0.020311956543392476
ANGELMAN SYNDROME (TYPE 2)	0.000541419	0.020311956543392476
15Q13.3 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
ADAMS-OLIVER SYNDROME 1; AOS1	0.000541419	0.020311956543392476
NEUROFIBROMATOSIS, TYPE II	0.000541419	0.020311956543392476
ADENYLOSUCCINASE DEFICIENCY	0.000541419	0.020311956543392476
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000541419	0.020311956543392476
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.000541419	0.020311956543392476
SECONDARY SYRINGOMYELIA	0.000541419	0.020311956543392476
BRANCHIOOCULOFACIAL SYNDROME	0.000541419	0.020311956543392476
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.000541419	0.020311956543392476
NIPAH VIRUS DISEASE	0.000541419	0.020311956543392476
HUNTINGTON DISEASE; HD	0.000541419	0.020311956543392476
ADRENOMYODYSTROPHY	0.000541419	0.020311956543392476
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000541419	0.020311956543392476
RECOMBINANT CHROMOSOME 8 SYNDROME	0.000541419	0.020311956543392476
RECOMBINANT 8 SYNDROME	0.000541419	0.020311956543392476
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000541419	0.020311956543392476
STURGE-WEBER SYNDROME	0.000541419	0.020311956543392476
SUPRABULBAR PARESIS, CONGENITAL	0.000541419	0.020311956543392476
DIGEORGE SYNDROME; DGS	0.000541419	0.020311956543392476
DISTAL MONOSOMY 19P13.3	0.000541419	0.020311956543392476
PREECLAMPSIA/ECLAMPSIA 1	0.000541419	0.020311956543392476
8P INVERTED DUPLICATION/DELETION SYNDROME	0.000541419	0.020311956543392476
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.000541419	0.020311956543392476
ACROCALLOSAL SYNDROME; ACLS	0.000541419	0.020311956543392476
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.000541419	0.020311956543392476
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.000541419	0.020311956543392476
ALEXANDER DISEASE	0.000541419	0.020311956543392476
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.000541419	0.020311956543392476
SNEDDON SYNDROME	0.000541419	0.020311956543392476
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.020311956543392476
POSTENCEPHALITIC PARKINSONISM	0.000541419	0.020311956543392476
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.000541419	0.020311956543392476
KBG SYNDROME	0.000541419	0.020311956543392476
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.000541419	0.020311956543392476
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000541419	0.020311956543392476
INSULINOMA	0.000541419	0.020311956543392476
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.000541419	0.020311956543392476
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.000541419	0.020311956543392476
HYPOMAGNESEMIA 2, RENAL	0.000541419	0.020311956543392476
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.000541419	0.020311956543392476
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.000541419	0.020311956543392476
NEUROFIBROMATOSIS, TYPE I	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000541419	0.020311956543392476
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.000541419	0.020311956543392476
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.020311956543392476
OCULODENTODIGITAL DYSPLASIA; ODDD	0.000541419	0.020311956543392476
PARIETAL FORAMINA	0.000541419	0.020311956543392476
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.000541419	0.020311956543392476
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.000541419	0.020311956543392476
RAPID-ONSET DYSTONIA-PARKINSONISM	0.000541419	0.020311956543392476
CLASSIC PHENYLKETONURIA	0.000541419	0.020311956543392476
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.000541419	0.020311956543392476
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.000541419	0.020311956543392476
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.000541419	0.020311956543392476
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.000541419	0.020311956543392476
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.000541419	0.020311956543392476
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000541419	0.020311956543392476
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.020311956543392476
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.000541419	0.020311956543392476
NEURAMINIDASE DEFICIENCY	0.000541419	0.020311956543392476
GLUTATHIONE SYNTHETASE DEFICIENCY	0.000541419	0.020311956543392476
PYRUVATE CARBOXYLASE DEFICIENCY	0.000541419	0.020311956543392476
RAMON SYNDROME	0.000541419	0.020311956543392476
CRIGLER-NAJJAR SYNDROME TYPE 1	0.000541419	0.020311956543392476
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.000541419	0.020311956543392476
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.000541419	0.020311956543392476
RETINAL DEGENERATION AND EPILEPSY	0.000541419	0.020311956543392476
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.000541419	0.020311956543392476
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.000541419	0.020311956543392476
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.000541419	0.020311956543392476
PHENYLKETONURIA	0.000541419	0.020311956543392476
ELEJALDE DISEASE	0.000541419	0.020311956543392476
SAETHRE-CHOTZEN SYNDROME	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.000541419	0.020311956543392476
ECTODERMAL DYSPLASIA SYNDROME	0.000541419	0.020311956543392476
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.000541419	0.020311956543392476
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.000541419	0.020311956543392476
MOGS-CDG	0.000541419	0.020311956543392476
ALG9-CDG	0.000541419	0.020311956543392476
ALG1-CDG	0.000541419	0.020311956543392476
ALG2-CDG	0.000541419	0.020311956543392476
MPDU1-CDG	0.000541419	0.020311956543392476
DPM1-CDG	0.000541419	0.020311956543392476
ALG3-CDG	0.000541419	0.020311956543392476
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.020311956543392476
L-2-HYDROXYGLUTARIC ACIDURIA	0.000541419	0.020311956543392476
EPISODIC ATAXIA TYPE 3	0.000541419	0.020311956543392476
DEND SYNDROME	0.000541419	0.020311956543392476
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.000541419	0.020311956543392476
ZUNICH NEUROECTODERMAL SYNDROME	0.000541419	0.020311956543392476
IMMUNOGLOBULIN A VASCULITIS	0.000541419	0.020311956543392476
6Q TERMINAL DELETION SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 14	0.000541419	0.020311956543392476
LISSENCEPHALY, X-LINKED, 1; LISX1	0.000541419	0.020311956543392476
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.000541419	0.020311956543392476
ADRENOLEUKODYSTROPHY	0.000541419	0.020311956543392476
RAYNAUD-CLAES SYNDROME; MRXSRC	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 21	0.000541419	0.020311956543392476
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.000541419	0.020311956543392476
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.000541419	0.020311956543392476
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 72	0.000541419	0.020311956543392476
ANGELMAN SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.000541419	0.020311956543392476
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.000541419	0.020311956543392476
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.000541419	0.020311956543392476
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.000541419	0.020311956543392476
INFANTILE REFSUM DISEASE	0.000541419	0.020311956543392476
SJOGREN-LARSSON SYNDROME; SLS	0.000541419	0.020311956543392476
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.000541419	0.020311956543392476
ACQUIRED PARTIAL LIPODYSTROPHY	0.000541419	0.020311956543392476
SULFOCYSTEINURIA	0.000541419	0.020311956543392476
FILIPPI SYNDROME; FLPIS	0.000541419	0.020311956543392476
RETT SYNDROME	0.000541419	0.020311956543392476
GM2-GANGLIOSIDOSIS, AB VARIANT	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.000541419	0.020311956543392476
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.000541419	0.020311956543392476
TAY-SACHS DISEASE; TSD	0.000541419	0.020311956543392476
THREONINEMIA	0.000541419	0.020311956543392476
THYROCEREBRORETINAL SYNDROME	0.000541419	0.020311956543392476
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.000541419	0.020311956543392476
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.000541419	0.020311956543392476
XYLOSIDASE DEFICIENCY	0.000541419	0.020311956543392476
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.000541419	0.020311956543392476
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.000541419	0.020311956543392476
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.000541419	0.020311956543392476
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.000541419	0.020311956543392476
KIFAFA SEIZURE DISORDER	0.000541419	0.020311956543392476
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.000541419	0.020311956543392476
KRABBE DISEASE	0.000541419	0.020311956543392476
MEHMO SYNDROME	0.000541419	0.020311956543392476
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.000541419	0.020311956543392476
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.000541419	0.020311956543392476
LANDAU-KLEFFNER SYNDROME	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.000541419	0.020311956543392476
FETAL GAUCHER DISEASE	0.000541419	0.020311956543392476
KEUTEL SYNDROME	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.000541419	0.020311956543392476
KETOADIPICACIDURIA	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.000541419	0.020311956543392476
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000541419	0.020311956543392476
HYPER-BETA-ALANINEMIA	0.000541419	0.020311956543392476
HYPERLEUCINE-ISOLEUCINEMIA	0.000541419	0.020311956543392476
DPAGT1-CDG	0.000541419	0.020311956543392476
HYPERLYSINEMIA, TYPE I	0.000541419	0.020311956543392476
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000541419	0.020311956543392476
HYPERPROLINEMIA, TYPE II	0.000541419	0.020311956543392476
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-ATAXIA-APRAXIA SYNDROME	0.000541419	0.020311956543392476
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.000541419	0.020311956543392476
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.000541419	0.020311956543392476
HYPOPHOSPHATASIA, CHILDHOOD	0.000541419	0.020311956543392476
BARAITSER-WINTER SYNDROME 1; BRWS1	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.000541419	0.020311956543392476
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000541419	0.020311956543392476
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.000541419	0.020311956543392476
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.000541419	0.020311956543392476
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000541419	0.020311956543392476
SJGREN-LARSSON SYNDROME	0.000541419	0.020311956543392476
SIALIDOSIS TYPE 1	0.000541419	0.020311956543392476
MIXED CONNECTIVE TISSUE DISEASE	0.000541419	0.020311956543392476
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.000541419	0.020311956543392476
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.000541419	0.020311956543392476
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.000541419	0.020311956543392476
47,XYY SYNDROME	0.000541419	0.020311956543392476
SCHIZENCEPHALY	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000541419	0.020311956543392476
SANDHOFF DISEASE	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.000541419	0.020311956543392476
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.000541419	0.020311956543392476
GRISCELLI SYNDROME TYPE 2	0.000541419	0.020311956543392476
GRISCELLI SYNDROME TYPE 1	0.000541419	0.020311956543392476
LEIGH SYNDROME; LS	0.000541419	0.020311956543392476
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000541419	0.020311956543392476
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000541419	0.020311956543392476
MACDERMOT-WINTER SYNDROME	0.000541419	0.020311956543392476
METACHROMATIC LEUKODYSTROPHY	0.000541419	0.020311956543392476
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.000541419	0.020311956543392476
TAY-SACHS DISEASE	0.000541419	0.020311956543392476
MARDEN-WALKER SYNDROME	0.000541419	0.020311956543392476
MEGALENCEPHALY WITH DYSMYELINATION	0.000541419	0.020311956543392476
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.000541419	0.020311956543392476
MELANOSIS, NEUROCUTANEOUS; NCMS	0.000541419	0.020311956543392476
ENCEPHALITIS LETHARGICA	0.000541419	0.020311956543392476
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.000541419	0.020311956543392476
CAMOS SYNDROME	0.000541419	0.020311956543392476
FREE SIALIC ACID STORAGE DISEASE	0.000541419	0.020311956543392476
SCRUB TYPHUS	0.000541419	0.020311956543392476
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000541419	0.020311956543392476
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.000541419	0.020311956543392476
ISOLATED SPINA BIFIDA	0.000541419	0.020311956543392476
SNEDDON SYNDROME	0.000541419	0.020311956543392476
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.000541419	0.020311956543392476
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.000541419	0.020311956543392476
4Q21 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.000541419	0.020311956543392476
15Q11Q13 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.000541419	0.020311956543392476
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.000541419	0.020311956543392476
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392476
DUBOWITZ SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.000541419	0.020311956543392476
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.000541419	0.020311956543392476
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000541419	0.020311956543392476
DUANE RETRACTION SYNDROME	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.000541419	0.020311956543392476
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.000541419	0.020311956543392476
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.000541419	0.020311956543392476
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.000541419	0.020311956543392476
CITRULLINEMIA TYPE II	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.000541419	0.020311956543392476
JOUBERT SYNDROME 30; JBTS30	0.000541419	0.020311956543392476
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.000541419	0.020311956543392476
AL KAISSI SYNDROME; ALKAS	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.000541419	0.020311956543392476
CENTRAL BILATERAL MACROGYRIA	0.000541419	0.020311956543392476
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.000541419	0.020311956543392476
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.000541419	0.020311956543392476
LOWRY-MACLEAN SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.000541419	0.020311956543392476
KLEEFSTRA SYNDROME 2; KLEFS2	0.000541419	0.020311956543392476
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.000541419	0.020311956543392476
CHROMOSOME 1P35 DELETION SYNDROME	0.000541419	0.020311956543392476
SPINOCEREBELLAR ATAXIA 47; SCA47	0.000541419	0.020311956543392476
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000541419	0.020311956543392476
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.000541419	0.020311956543392476
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.000541419	0.020311956543392476
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.000541419	0.020311956543392476
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.000541419	0.020311956543392476
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.000541419	0.020311956543392476
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000541419	0.020311956543392476
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.000541419	0.020311956543392476
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.000541419	0.020311956543392476
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.000541419	0.020311956543392476
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.000541419	0.020311956543392476
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.000541419	0.020311956543392476
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.000541419	0.020311956543392476
5Q35 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392476
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.000541419	0.020311956543392476
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.000541419	0.020311956543392476
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000541419	0.020311956543392476
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.000541419	0.020311956543392476
JABERI-ELAHI SYNDROME; JABELS	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.000541419	0.020311956543392476
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.000541419	0.020311956543392476
HYPEREKPLEXIA 4; HKPX4	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.000541419	0.020311956543392476
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.000541419	0.020311956543392476
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.000541419	0.020311956543392476
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.000541419	0.020311956543392476
NEUROCUTANEOUS MELANOCYTOSIS	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.000541419	0.020311956543392476
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000541419	0.020311956543392476
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000541419	0.020311956543392476
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.000541419	0.020311956543392476
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.000541419	0.020311956543392476
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.000541419	0.020311956543392476
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.000541419	0.020311956543392476
MOYNAHAN SYNDROME	0.000541419	0.020311956543392476
MOYAMOYA DISEASE	0.000541419	0.020311956543392476
MOMO SYNDROME	0.000541419	0.020311956543392476
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.000541419	0.020311956543392476
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.000541419	0.020311956543392476
SUDDEN CARDIAC FAILURE, INFANTILE	0.000541419	0.020311956543392476
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.000541419	0.020311956543392476
IMMUNODEFICIENCY 49; IMD49	0.000541419	0.020311956543392476
MICROSPORIDIOSIS	0.000541419	0.020311956543392476
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.000541419	0.020311956543392476
LINEAR VERRUCOUS NEVUS SYNDROME	0.000541419	0.020311956543392476
JUVENILE HUNTINGTON DISEASE	0.000541419	0.020311956543392476
MONOSOMY 9P	0.000541419	0.020311956543392476
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.000541419	0.020311956543392476
MIRAGE SYNDROME; MIRAGE	0.000541419	0.020311956543392476
20Q13.33 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
20P12.3 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
17Q12 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.000541419	0.020311956543392476
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.000541419	0.020311956543392476
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.000541419	0.020311956543392476
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.000541419	0.020311956543392476
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392476
LINEAR NEVUS SEBACEUS SYNDROME	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.000541419	0.020311956543392476
15Q14 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.000541419	0.020311956543392476
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.000541419	0.020311956543392476
LISSENCEPHALY 8; LIS8	0.000541419	0.020311956543392476
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.000541419	0.020311956543392476
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.000541419	0.020311956543392476
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.000541419	0.020311956543392476
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.000541419	0.020311956543392476
MICRO SYNDROME	0.000541419	0.020311956543392476
1Q41Q42 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
1Q21.1 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392476
1Q21.1 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.000541419	0.020311956543392476
AICA-RIBOSIDURIA	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.000541419	0.020311956543392476
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.000541419	0.020311956543392476
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.000541419	0.020311956543392476
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.000541419	0.020311956543392476
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.000541419	0.020311956543392476
3Q29 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392476
6Q25 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.000541419	0.020311956543392476
PINEOBLASTOMA	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.000541419	0.020311956543392476
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.000541419	0.020311956543392476
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
19P13.12 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.000541419	0.020311956543392476
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.000541419	0.020311956543392476
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.000541419	0.020311956543392476
8P23.1 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.000541419	0.020311956543392476
SUBEPENDYMOMA	0.000541419	0.020311956543392476
EPENDYMOMA	0.000541419	0.020311956543392476
PSEUDO-TORCH SYNDROME 2	0.000541419	0.020311956543392476
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.000541419	0.020311956543392476
CK SYNDROME	0.000541419	0.020311956543392476
MATERNAL PHENYLKETONURIA	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.000541419	0.020311956543392476
CLASSIC HOMOCYSTINURIA	0.000541419	0.020311956543392476
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.000541419	0.020311956543392476
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.000541419	0.020311956543392476
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.000541419	0.020311956543392476
BRANCHIOSKELETOGENITAL SYNDROME	0.000541419	0.020311956543392476
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.000541419	0.020311956543392476
DYSEQUILIBRIUM SYNDROME	0.000541419	0.020311956543392476
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.000541419	0.020311956543392476
SYMMETRICAL THALAMIC CALCIFICATIONS	0.000541419	0.020311956543392476
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.000541419	0.020311956543392476
BETA-KETOTHIOLASE DEFICIENCY	0.000541419	0.020311956543392476
22Q11.2 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392476
CADASIL	0.000541419	0.020311956543392476
CONGENITAL DISORDER OF GLYCOSYLATION	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.000541419	0.020311956543392476
HISTIOCYTOID CARDIOMYOPATHY	0.000541419	0.020311956543392476
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.000541419	0.020311956543392476
PROGRESSIVE HEMIFACIAL ATROPHY	0.000541419	0.020311956543392476
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.000541419	0.020311956543392476
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.000541419	0.020311956543392476
BETA-MANNOSIDOSIS	0.000541419	0.020311956543392476
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.000541419	0.020311956543392476
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.000541419	0.020311956543392476
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.000541419	0.020311956543392476
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.000541419	0.020311956543392476
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.000541419	0.020311956543392476
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.000541419	0.020311956543392476
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.000541419	0.020311956543392476
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.000541419	0.020311956543392476
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000541419	0.020311956543392476
THANATOPHORIC DYSPLASIA TYPE 1	0.000541419	0.020311956543392476
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.000541419	0.020311956543392476
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.000541419	0.020311956543392476
BEHET DISEASE	0.000541419	0.020311956543392476
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.000541419	0.020311956543392476
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.000541419	0.020311956543392476
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.000541419	0.020311956543392476
DISTAL TRISOMY 15Q	0.000541419	0.020311956543392476
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.000541419	0.020311956543392476
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.000541419	0.020311956543392476
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.000541419	0.020311956543392476
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.000541419	0.020311956543392476
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.000541419	0.020311956543392476
FAMILIAL BENIGN COPPER DEFICIENCY	0.000541419	0.020311956543392476
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.000541419	0.020311956543392476
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.000541419	0.020311956543392476
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.000541419	0.020311956543392476
2P21 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
DISTAL MONOSOMY 7Q36	0.000541419	0.020311956543392476
DISTAL MONOSOMY 3P	0.000541419	0.020311956543392476
2Q24 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
HUNTINGTON DISEASE-LIKE 1	0.000541419	0.020311956543392476
HUNTINGTON DISEASE-LIKE 3	0.000541419	0.020311956543392476
ROSA-DORFMAN DISEASE	0.000541419	0.020311956543392476
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.000541419	0.020311956543392476
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.020311956543392476
MULTIPLE CARBOXYLASE DEFICIENCY	0.000541419	0.020311956543392476
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.000541419	0.020311956543392476
17Q11.2 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.000541419	0.020311956543392476
ISOLATED CEREBELLAR AGENESIS	0.000541419	0.020311956543392476
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.000541419	0.020311956543392476
CHILDHOOD DISINTEGRATIVE DISORDER	0.000541419	0.020311956543392476
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.000541419	0.020311956543392476
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.000541419	0.020311956543392476
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.000541419	0.020311956543392476
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.020311956543392476
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.020311956543392476
RING CHROMOSOME 10 SYNDROME	0.000541419	0.020311956543392476
CHDIAK-HIGASHI SYNDROME	0.000541419	0.020311956543392476
WOLCOTT-RALLISON SYNDROME	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.000541419	0.020311956543392476
FRONTAL ENCEPHALOCELE	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.000541419	0.020311956543392476
HENNEKAM SYNDROME	0.000541419	0.020311956543392476
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000541419	0.020311956543392476
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.000541419	0.020311956543392476
CYSTATHIONINURIA	0.000541419	0.020311956543392476
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.000541419	0.020311956543392476
HARTNUP DISEASE	0.000541419	0.020311956543392476
HARROD SYNDROME	0.000541419	0.020311956543392476
HALL-RIGGS SYNDROME	0.000541419	0.020311956543392476
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.000541419	0.020311956543392476
EPISODIC ATAXIA TYPE 6	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.000541419	0.020311956543392476
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.000541419	0.020311956543392476
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.000541419	0.020311956543392476
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.000541419	0.020311956543392476
OPTIC PATHWAY GLIOMA	0.000541419	0.020311956543392476
HENNEKAM-BEEMER SYNDROME	0.000541419	0.020311956543392476
HERNNDEZ-AGUIRRE NEGRETE SYNDROME	0.000541419	0.020311956543392476
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.000541419	0.020311956543392476
DONNAI-BARROW SYNDROME	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.000541419	0.020311956543392476
CONGENITAL HYDROCEPHALUS	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000541419	0.020311956543392476
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.000541419	0.020311956543392476
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.000541419	0.020311956543392476
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.000541419	0.020311956543392476
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.000541419	0.020311956543392476
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.000541419	0.020311956543392476
NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.020311956543392476
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.000541419	0.020311956543392476
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.000541419	0.020311956543392476
NODULAR NEURONAL HETEROTOPIA	0.000541419	0.020311956543392476
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.000541419	0.020311956543392476
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.020311956543392476
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.000541419	0.020311956543392476
COFFIN-SIRIS SYNDROME 8; CSS8	0.000541419	0.020311956543392476
FAMILIAL MULTIPLE LIPOMATOSIS	0.000541419	0.020311956543392476
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.000541419	0.020311956543392476
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.000541419	0.020311956543392476
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.000541419	0.020311956543392476
EPILEPSY-TELANGIECTASIA SYNDROME	0.000541419	0.020311956543392476
BENIGN FAMILIAL NEONATAL EPILEPSY	0.000541419	0.020311956543392476
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.000541419	0.020311956543392476
ATAXIA-TELANGIECTASIA	0.000541419	0.020311956543392476
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.000541419	0.020311956543392476
ABETA AMYLOIDOSIS, DUTCH TYPE	0.000541419	0.020311956543392476
2Q37 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392476
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.000541419	0.020311956543392476
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.000541419	0.020311956543392476
EAST SYNDROME	0.000541419	0.020311956543392476
FLYNN-AIRD SYNDROME	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.000541419	0.020311956543392476
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.000541419	0.020311956543392476
FRYNS SYNDROME	0.000541419	0.020311956543392476
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.000541419	0.020311956543392476
CRIGLER-NAJJAR SYNDROME	0.000541419	0.020311956543392476
FOIX-CHAVANY-MARIE SYNDROME	0.000541419	0.020311956543392476
PULMONARY ARTERIOVENOUS MALFORMATION	0.000541419	0.020311956543392476
ADULT-ONSET DYSTONIA-PARKINSONISM	0.000541419	0.020311956543392476
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392476
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.000541419	0.020311956543392476
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.000541419	0.020311956543392476
COWDEN SYNDROME	0.000541419	0.020311956543392476
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.000541419	0.020311956543392476
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.000541419	0.020311956543392476
XP21 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.000541419	0.020311956543392476
TETRASOMY 5P	0.000541419	0.020311956543392476
BARAITSER-WINTER SYNDROME 2; BRWS2	0.000541419	0.020311956543392476
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.000541419	0.020311956543392476
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000541419	0.020311956543392476
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.000541419	0.020311956543392476
MERCURY POISONING	0.000541419	0.020311956543392476
ISOVALERIC ACIDEMIA	0.000541419	0.020311956543392476
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.000541419	0.020311956543392476
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.000541419	0.020311956543392476
SECKEL SYNDROME 7; SCKL7	0.000541419	0.020311956543392476
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.000541419	0.020311956543392476
TAKAYASU ARTERITIS	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.000541419	0.020311956543392476
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.000541419	0.020311956543392476
TETRASOMY 18P	0.000541419	0.020311956543392476
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.000541419	0.020311956543392476
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.000541419	0.020311956543392476
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.000541419	0.020311956543392476
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.000541419	0.020311956543392476
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000541419	0.020311956543392476
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.000541419	0.020311956543392476
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000541419	0.020311956543392476
DISTAL TRISOMY 17Q	0.000541419	0.020311956543392476
TRISOMY 13	0.000541419	0.020311956543392476
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.000541419	0.020311956543392476
TRISOMY X	0.000541419	0.020311956543392476
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.000541419	0.020311956543392476
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.000541419	0.020311956543392476
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.000541419	0.020311956543392476
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.000541419	0.020311956543392476
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.000541419	0.020311956543392476
THYROCEREBRORENAL SYNDROME	0.000541419	0.020311956543392476
FILIPPI SYNDROME	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.000541419	0.020311956543392476
ZLOTOGORA-OGUR SYNDROME	0.000541419	0.020311956543392476
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.000541419	0.020311956543392476
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.000541419	0.020311956543392476
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.000541419	0.020311956543392476
HEREDITARY HYPEREKPLEXIA	0.000541419	0.020311956543392476
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.000541419	0.020311956543392476
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.000541419	0.020311956543392476
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000541419	0.020311956543392476
RIFT VALLEY FEVER	0.000541419	0.020311956543392476
EBOLA HEMORRHAGIC FEVER	0.000541419	0.020311956543392476
LUJO HEMORRHAGIC FEVER	0.000541419	0.020311956543392476
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.000541419	0.020311956543392476
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.000541419	0.020311956543392476
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.000541419	0.020311956543392476
SIALURIA	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.000541419	0.020311956543392476
STURGE-WEBER SYNDROME	0.000541419	0.020311956543392476
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.000541419	0.020311956543392476
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.000541419	0.020311956543392476
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.000541419	0.020311956543392476
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.000541419	0.020311956543392476
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392476
COWDEN SYNDROME 5; CWS5	0.000541419	0.020311956543392476
EARLY-ONSET LAFORA BODY DISEASE	0.000541419	0.020311956543392476
LISSENCEPHALY 5; LIS5	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.000541419	0.020311956543392476
RENPENNING SYNDROME	0.000541419	0.020311956543392476
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.000541419	0.020311956543392476
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.000541419	0.020311956543392476
COWDEN SYNDROME 6; CWS6	0.000541419	0.020311956543392476
FOUNTAIN SYNDROME	0.000541419	0.020311956543392476
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.000541419	0.020311956543392476
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.000541419	0.020311956543392476
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.000541419	0.020311956543392476
GABA-TRANSAMINASE DEFICIENCY	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.000541419	0.020311956543392476
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.000541419	0.020311956543392476
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392476
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.000541419	0.020311956543392476
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.000541419	0.020311956543392476
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.000541419	0.020311956543392476
DISTAL MONOSOMY 15Q	0.000541419	0.020311956543392476
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.000541419	0.020311956543392476
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.000541419	0.020311956543392476
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.000541419	0.020311956543392476
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.000541419	0.020311956543392476
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.000541419	0.020311956543392476
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000541419	0.020311956543392476
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.000541419	0.020311956543392476
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.000541419	0.020311956543392476
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000541419	0.020311956543392476
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.000541419	0.020311956543392476
HSD10 DISEASE	0.000541419	0.020311956543392476
ATYPICAL JUVENILE PARKINSONISM	0.000541419	0.020311956543392476
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.000541419	0.020311956543392476
EPISODIC ATAXIA, TYPE 6	0.000541419	0.020311956543392476
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.000541419	0.020311956543392476
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.000541419	0.020311956543392476
GRISCELLI SYNDROME	0.000541419	0.020311956543392476
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.020311956543392476
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.000541419	0.020311956543392476
SIMPSON-GOLABI-BEHMEL SYNDROME	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.000541419	0.020311956543392476
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.000541419	0.020311956543392476
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000541419	0.020311956543392476
DISTAL MONOSOMY 1Q	0.000541419	0.020311956543392476
20Q11.2 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392476
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.000541419	0.020311956543392476
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.000541419	0.020311956543392476
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.000541419	0.020311956543392476
GALACTOSIALIDOSIS	0.000541419	0.020311956543392476
INFANTILE NEUROAXONAL DYSTROPHY	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000541419	0.020311956543392476
FUCOSIDOSIS	0.000541419	0.020311956543392476
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.020311956543392476
CHIME SYNDROME	0.000541419	0.020311956543392476
ZIMMERMANN-LABAND SYNDROME	0.000541419	0.020311956543392476
WORSTER-DROUGHT SYNDROME	0.000541419	0.020311956543392476
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000541419	0.020311956543392476
ADAMS-OLIVER SYNDROME 2; AOS2	0.000541419	0.020311956543392476
WILSON-TURNER SYNDROME	0.000541419	0.020311956543392476
WARBURG MICRO SYNDROME 3; WARBM3	0.000541419	0.020311956543392476
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.000541419	0.020311956543392476
WHIPPLE DISEASE	0.000541419	0.020311956543392476
MECKEL SYNDROME, TYPE 10; MKS10	0.000541419	0.020311956543392476
PERRAULT SYNDROME 3	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.000541419	0.020311956543392476
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.000541419	0.020311956543392476
GLIOBLASTOMA	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.000541419	0.020311956543392476
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.000541419	0.020311956543392476
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.000541419	0.020311956543392476
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.000541419	0.020311956543392476
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.000541419	0.020311956543392476
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.000541419	0.020311956543392476
LISSENCEPHALY 4	0.000541419	0.020311956543392476
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.000541419	0.020311956543392476
GM1 GANGLIOSIDOSIS	0.000541419	0.020311956543392476
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.000541419	0.020311956543392476
N-ACETYLASPARTATE DEFICIENCY; NACED	0.000541419	0.020311956543392476
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.000541419	0.020311956543392476
SEVERE CANAVAN DISEASE	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.000541419	0.020311956543392476
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.000541419	0.020311956543392476
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.000541419	0.020311956543392476
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.000541419	0.020311956543392476
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.000541419	0.020311956543392476
WOLF-HIRSCHHORN SYNDROME	0.000541419	0.020311956543392476
INFANTILE LIVER FAILURE SYNDROME 2	0.000541419	0.020311956543392476
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392476
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392476
NASU-HAKOLA DISEASE	0.000541419	0.020311956543392476
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.000541419	0.020311956543392476
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.000541419	0.020311956543392476
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.000541419	0.020311956543392476
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000541419	0.020311956543392476
10Q22.3Q23.3 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.000541419	0.020311956543392476
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000541419	0.020311956543392476
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.000541419	0.020311956543392476
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.000541419	0.020311956543392476
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.000541419	0.020311956543392476
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.000541419	0.020311956543392476
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.000541419	0.020311956543392476
XP22.13P22.2 DUPLICATION SYNDROME	0.000541419	0.020311956543392476
TYROSINEMIA TYPE 2	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.000541419	0.020311956543392476
INHERITED CREUTZFELDT-JAKOB DISEASE	0.000541419	0.020311956543392476
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.000541419	0.020311956543392476
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.000541419	0.020311956543392476
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.000541419	0.020311956543392476
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392476
L1 SYNDROME	0.000541419	0.020311956543392476
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.000541419	0.020311956543392476
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.000541419	0.020311956543392476
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.000541419	0.020311956543392476
THANATOPHORIC DYSPLASIA	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.000541419	0.020311956543392476
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.000541419	0.020311956543392476
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.000541419	0.020311956543392476
HEART AND BRAIN MALFORMATION SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.000541419	0.020311956543392476
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.000541419	0.020311956543392476
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.000541419	0.020311956543392476
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.000541419	0.020311956543392476
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.000541419	0.020311956543392476
CHROMOSOME 16P13.2 DELETION SYNDROME	0.000541419	0.020311956543392476
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.000541419	0.020311956543392476
LUSCAN-LUMISH SYNDROME; LLS	0.000541419	0.020311956543392476
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.000541419	0.020311956543392476
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.000541419	0.020311956543392476
OROFACIODIGITAL SYNDROME TYPE 1	0.000541419	0.020311956543392476
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.000541419	0.020311956543392476
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.000541419	0.020311956543392476
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.000541419	0.020311956543392476
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.000541419	0.020311956543392476
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.000541419	0.020311956543392476
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.000541419	0.020311956543392476
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.000541419	0.020311956543392476
OCULODENTODIGITAL DYSPLASIA	0.000541419	0.020311956543392476
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.000541419	0.020311956543392476
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.000541419	0.020311956543392476
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.000541419	0.020311956543392476
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.000541419	0.020311956543392476
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392476
PHAKOMATOSIS PIGMENTOVASCULARIS	0.000541419	0.020311956543392476
TARP SYNDROME	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.000541419	0.020311956543392476
GM2 GANGLIOSIDOSIS, AB VARIANT	0.000541419	0.020311956543392476
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000541419	0.020311956543392476
INTELLECTUAL DISABILITY, WOLFF TYPE	0.000541419	0.020311956543392476
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.000541419	0.020311956543392476
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.000541419	0.020311956543392476
FADD-RELATED IMMUNODEFICIENCY	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.000541419	0.020311956543392476
BENIGN FAMILIAL INFANTILE EPILEPSY	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.000541419	0.020311956543392476
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.000541419	0.020311956543392476
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.000541419	0.020311956543392476
CHROMOSOME 5Q12 DELETION SYNDROME	0.000541419	0.020311956543392476
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.000541419	0.020311956543392476
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.000541419	0.020311956543392476
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.000541419	0.020311956543392476
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.000541419	0.020311956543392476
INFANTILE LIVER FAILURE SYNDROME 1	0.000541419	0.020311956543392476
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000541419	0.020311956543392476
20P13 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.000541419	0.020311956543392476
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.000541419	0.020311956543392476
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.000541419	0.020311956543392476
RUVALCABA SYNDROME	0.000541419	0.020311956543392476
NOCARDIOSIS	0.000541419	0.020311956543392476
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.000541419	0.020311956543392476
ATYPICAL RETT SYNDROME	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.000541419	0.020311956543392476
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.000541419	0.020311956543392476
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.000541419	0.020311956543392476
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.000541419	0.020311956543392476
PERRAULT SYNDROME 5; PRLTS5	0.000541419	0.020311956543392476
PORENCEPHALY	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.000541419	0.020311956543392476
CATEL-MANZKE SYNDROME; CATMANS	0.000541419	0.020311956543392476
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.000541419	0.020311956543392476
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.000541419	0.020311956543392476
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.000541419	0.020311956543392476
CRONKHITE-CANADA SYNDROME	0.000541419	0.020311956543392476
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.000541419	0.020311956543392476
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.000541419	0.020311956543392476
TENORIO SYNDROME; TNORS	0.000541419	0.020311956543392476
CONGENITAL RUBELLA SYNDROME	0.000541419	0.020311956543392476
MEVALONIC ACIDURIA	0.000541419	0.020311956543392476
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.000541419	0.020311956543392476
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.000541419	0.020311956543392476
LEUKOCYTE ADHESION DEFICIENCY	0.000541419	0.020311956543392476
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.000541419	0.020311956543392476
RAMON SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.000541419	0.020311956543392476
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.000541419	0.020311956543392476
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.000541419	0.020311956543392476
ADAMS-OLIVER SYNDROME 5; AOS5	0.000541419	0.020311956543392476
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.000541419	0.020311956543392476
11P15.4 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392476
IMMUNODEFICIENCY 37; IMD37	0.000541419	0.020311956543392476
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.000541419	0.020311956543392476
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.000541419	0.020311956543392476
SPONTANEOUS PERIODIC HYPOTHERMIA	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.000541419	0.020311956543392476
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.000541419	0.020311956543392476
WOLF-HIRSCHHORN SYNDROME	0.000541419	0.020311956543392476
